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Women and men differ in a wide variety of behavioral traits and in their vulnerability to
developing certain mental disorders. This review endeavors to explore how recent pre-
clinical and clinical research ﬁndings have enhanced our understanding of the factors that
underlie these disparities.We start with a brief overview of some of the important genetic,
molecular, and hormonal determinants that contribute to the process of sexual differen-
tiation. We then discuss the importance of animal models in studying the mechanisms
responsible for sex differences in neuropsychiatric disorders (e.g., drug dependence) –
with a special emphasis on experimental models based on the neurodevelopmental and
“three hits” hypotheses. Next, we describe the most common brain phenotypes observed
in vivo with magnetic resonance imaging. We discuss the challenges in interpreting these
phenotypes vis-à-vis the underlying neurobiology and revisit the known sex differences
in brain structure from birth, through adolescence, and into adulthood. This is followed
by a presentation of pertinent clinical and epidemiological data that point to important sex
differences in the prevalence, course, and expression of psychopathologies such as schizo-
phrenia, and mood disorders including major depression and posttraumatic stress disorder.
Recent evidence implies that mood disorders and psychosis share some common genetic
predispositions and neurobiological bases. Therefore, modern research is emphasizing
dimensional representation of mental disorders and conceptualization of schizophrenia
and major depression as a continuum of cognitive deﬁcits and neurobiological abnormali-
ties. Herein, we examine available evidence on cerebral sexual dimorphism to verify if sex
differences vary quantitatively and/or qualitatively along the psychoses-depression contin-
uum. Finally, sex differences in the prevalence of posttraumatic disorder and drug abuse
have been described, and we consider the genomic and molecular data supporting these
differences.
Keywords: sexual differentiation, adolescence, schizophrenia, depression, bipolar disorders, posttraumatic disor-
ders, addiction, animal models
INTRODUCTION
Psychiatric disorders and drug dependence are very important
issues for healthcare systems that affect millions of people each
year, and according to the National Institute of Mental Health
(NIMH) only a small fraction of those patients receive an adequate
treatment. These afﬂictions include anxiety and posttraumatic
stress disorder (PTSD), attention-deﬁcit hyperactivity disorder,
autism, eating disorders, mood disorders (depression, bipolar dis-
order, BP), personality disorder, schizophrenia and drug abuse,
and dependence1. As explained in the sections that follow many
1www.nimh.nih.gov/statistics
of them begin early in life (Kessler et al., 2007), and their high
prevalence and social impact, especially for caregivers, demand a
major effort for their prevention, correct diagnosis, and treatment.
Thus, understanding their nature and origin is one of the most
challenging enterprises of modern biomedical research. Clinical
observations and epidemiological data reveal important sex dif-
ferences in the prevalence and expression of various mental health
problems and drug abuse.
A signiﬁcant weakness in the research of psychiatric disorders
and drug abuse is that despite all of the evidence suggesting that
the susceptibility, prevalence, progression, and/or severity of this
common disorders are sex-dependent, most studies with animals
have been focused on one sex (usuallymales) or failed to report the
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sex of the animals (Beery and Zucker, 2011). In addition, females
are underrepresented or even excluded in clinical and preclinical
studies (Rubino and Parolaro, 2011). However, the majority of
investigations examining estrogenic effects in the brain (e.g., neu-
roprotection, neuroinﬂammation, neurogenesis, migration) have
been performed in females, which contrasts with the extended use
of males in basic neuroscience research (Gillies and McArthur,
2010). This traditional view should be replaced with a new one
that recognizes the sexual dimorphisms in the susceptibility to
psychiatric disorders, which will help advance and evaluate the
effectiveness of treatments depending on the sex. Here we pro-
vide more detailed information of these sexual dimorphisms to
emphasize the urgent need to study both sexes to order to gain a
proper understanding of these disorders.
MECHANISMS INVOLVED IN SEXUAL DIFFERENTIATION OF
THE REPRODUCTIVE AND CENTRAL NERVOUS SYSTEMS
SEXUAL DIFFERENTIATION OF THE REPRODUCTIVE SYSTEM
Sexual differentiation inmammals is initiated in utero during early
gestation and is triggered, in large part, by the sex-determining
region of theY chromosome (SRY) gene located on theY chromo-
some. The SRY gene encodes a protein termed testis-determining
factor (TDF) that, along with SRY box-containing proteins like
Sox9, directs the differentiation of the primordial gonadal cells
into the testes (Maatouk and Capel, 2008; Bhandari et al., 2011).
TDF inhibits the expression of a X-linked gene named DAX1,
whose duplication within Xp21.3 causes XY sex reversal and there-
fore represses male-speciﬁc gene expression (Vilain and McCabe,
1998). SOX proteins stimulate the expression of steroidogenic fac-
tor 1 (SF-1; Shen and Ingraham, 2002), and Sox9 works together
with SF-1 to stimulate the expression of Mullerian-inhibiting sub-
stance (MIS; a.k.a. Mullerian regression factor and anti-Mullerian
hormone) in developing Sertoli cells (De Santa et al., 1998;Arango
et al., 1999). Missense mutations in the Sox9 high mobility group
(HMG) domain lead to XY sex reversal, whereas insertion of
a color coat transgene into the Sox9 regulatory region upregu-
lates expression and leads to XX sex reversal in mice (Bernard
et al., 2003; Canastar et al., 2008). Human chorionic gonadotropin
(hCG) secreted by the trophoblast also increases the expression
of SF-1 (Manna et al., 1999), thereby stimulating the Leydig and
Sertoli cells within the fetal testes to synthesize and secrete testos-
terone and MIS, respectively. Testosterone stimulates the Wolfﬁan
duct to develop into the male reproductive tract. In the primordial
external genital tissue, testosterone is converted to dihydrotestos-
terone (DHT) via 5α-reductase, and DHT thus formed stimulates
the development of accessory sex glands, penis, and scrotum.
This androgen-induced masculinization of the external genitalia
can be attributed, in part, to decreased Wnt/β-catenin signaling
(Miyagawa et al., 2009). The testicular secretion of MIS elicits the
apoptotic regression of the Mullerian duct by activating aWnt4/β-
catenin pathway in the Mullerian duct mesenchyme (Kobayashi
et al., 2011). Without the hCG-induced MIS and testosterone
secretion theMullerianductwill develop into the female reproduc-
tive tract, while theWolfﬁan duct declines. This may also be attrib-
uted, in part, to Wnt/β-catenin signaling in the genetic/gonadal
female that decreases the expression of Sox9 and MIS while pro-
moting the expression of the female cell markers Bmp2 and Rspo1
(Bernard et al., 2012). The organizational effects imparted by
a combination of in utero and neonatal testosterone surges are
required for full expression of male characteristics (Naftolin et al.,
1996; Resko and Roselli, 1997).
SEXUAL DIFFERENTIATION OF THE NERVOUS SYSTEM
The SRY /MIS/testosterone triad produces changes in the central
nervous system (CNS) that parallel the divergence of the primor-
dial gonads and external genitalia. SRY transcripts can be detected
in murine brain as early as E11, and SRY expression continues on
through postnatal day (PND) 30 in the midbrain, diencephalon,
and cortex (Mayer et al., 2000). The SRY gene also regulates the
expression of the X-linked monoamine oxidase type A gene in
human male neuroblastoma cells, which may help explain sex
differences in the prevalence of developmental neuropsychiatric
disorders like autism and attention-deﬁcit hyperactivity disor-
der (Wu et al., 2009). The expression of the SRY gene and the
subsequent formation of the testes and secretion of testosterone
masculinize the pattern of progesterone receptor expression in the
brain (Wagner et al., 2004). In utero testosterone elicits an increase
in the size of the sexually dimorphic nucleus of the preoptic area
during late gestation (Roselli et al., 2011). In addition, cerebel-
lar neurons express MIS receptors and the testicular secretion of
MIS, along with testosterone, increases Purkinje cell number and
cerebellar size in males (Wittmann and McLennan, 2011). How-
ever, recent evidence suggests that neuronal steroidogenesis may
contribute to sexual differentiation of the rat brain as removal of
peripheral sources of sex steroids at birth failed to abolish the sex-
and region-speciﬁc changes in the brain concentrations of these
hormones (Konkle and McCarthy, 2011).
There are also sex differences in gene expression occurring in
the murine brain as early as 10.5 days post-coitum, which pre-
cedes the in utero testosterone surge (Dewing et al., 2003). Many
of these genes reside on autosomes, and include Cyp7b (involved
in neurosteroid metabolism) and Rorα4 (implicated in Purkinje
cell differentiation). Others are located on either the X or Y chro-
mosome, and among them are Xist (involved in X inactivation),
Dby, and Eif2s3y (both of which are implicated in male fertility
and other neural and behavioral phenotypes). Similar observa-
tions were made by Xu et al. (2002), who found that six X-linked
murine genes (Usp9x, Ube1x, Smcx, Eif2s3x, Utx, and Dbx) were
expressed to a higher degree in the brains of adult females, regard-
less of inactivation status. For some of these genes (Smcx, Eif2s3x,
and Dbx), it appears that this differential expression is encoun-
tered as early as 13.5 days post-coitus. Not unexpectedly, the six
homologs on the Y chromosome (Usp9y, Ube1y, Smcy, Eif2s3y,
Uty, and Dby) are expressed in the brains of male but not female
mice. Their expression was evident in genetic males lacking the
SRY gene; indicating that testicular secretions are not required.
The expression of at least some of these genes (Smcy, Eif2s3y,
and Dby) occurs in a developmentally regulated fashion. Inter-
estingly, the sex difference in the expression of the X-linked genes,
at least in the adult murine brain, is not compensated by expres-
sion of the Y chromosome homologs in the brains of male mice.
Given that these genes encode proteins involved in functions rang-
ing from ubiquitination to protein translation; this suggests that
the disparate dosages of these sex chromosomal genes may also
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contribute to sex differences in neural development, at least at
some points along the developmental continuum.
Studies using the four-core genotype (FCG) mice, in which
sex chromosome complement (XX versus XY) is unrelated to the
animal’s gonadal sex, have revealed that inequities in sex chro-
mosomal complement can also contribute to sexually dimorphic
traits that would include the number of embryonic mesencephalic
dopamineneurons and thedensity of vasopressinergic innervation
of the lateral septum, both of which are greater in XY animals than
in XX animals (Arnold and Chen, 2009). Other sexually differenti-
ated neurobehavioral parameters inﬂuenced by sex chromosomal
complement include aggression (greater in XY than XX females),
pup retrieval (highest in XX females), social interaction (less in XX
than XY females in response to an intruder), nociception (shorter
response latencies in XX than in XY animals as assessed via hot-
plate and formalin tests), habit formation (greater in XX than in
XY animals), as well as susceptibility to neural tube and autoim-
mune disorders (higher in XX mice; Arnold and Chen, 2009). The
disparities inmanyof these neurobehavioral parameters are clearly
shaped by organizational as well as activational effects of gonadal
steroids (e.g., vasopressin expression in the septum, aggression,
parental behavior, and nociception), whereas sex differences in
other characteristics occur prior to, and therefore independent
of, the in utero/neonatal testosterone surge (e.g., mesencephalic
dopaminergic cell number, incidence of neural tube disorders;
de Vries et al., 1986; Han and de Vries, 2003; Craft et al., 2004;
Gatewood et al., 2006; Arnold and Chen, 2009). Regardless, SRY
gene expression and the testosterone surges that occur as a result
precludes a number of estrogenic responses including, but not
limited to, calcium signaling in hypothalamic astrocytes and the
generation of a preovulatory gonadotropin-releasing hormone
(GnRH) surge, both of which happen only in gonadal females
(Resko and Roselli, 1997; Kuo et al., 2010). However, while male
brains are unresponsive to many estrogenic effects, aromatase is
expressed in many brain regions throughout the critical period
of brain sexual differentiation (Mura et al., 2010), which suggests
that estrogens are instrumental for at least some aspects of male
neurogenic development including cell proliferation, survival and
death, synaptogenesis and dendritic branching, CpG methylation
and histone deacetylation in the hypothalamus and limbic system
(McCarthy and Arnold, 2011), as well as cognitive function and
affective behaviors regulated by the frontal cortex (Peruffo et al.,
2011).
Like the SRY gene product TDF, SOX proteins play a signiﬁ-
cant role in brain development and sexual differentiation of the
CNS. Of these, SOX9 and SOX11 are expressed primarily within
the CNS. SOX9 is highly conserved across phyla, and is expressed
at high levels during the embryonic development of marsupial,
murine, and human brain (Pask et al., 2002). SOX9 expression
can be detected as early as 7.75 days post-coitus within cranial
neural crest cells of the hindbrain neural folds, and its expression
within the ﬁrst pharyngeal arch is dependent upon the canoni-
cal Wnt/β-catenin signaling pathway (Bagheri-Fam et al., 2006).
By 11.5 days post-coitum its expression extends to the ventricu-
lar zone of the neuroectoderm that gives rise to the forebrain,
midbrain, hindbrain, and spinal cord (Bagheri-Fam et al., 2006).
As early as E18.5 SOX9 expression is reported to extend out into
the granular cell and Purkinje cell layers of the rodent cerebel-
lum, and co-localize with the Bergmann glial cell marker vimentin
(Pompolo and Harley, 2001; Scotting et al., 2005). In adult rodent
forebrain SOX9 is co-expressed with the astrocyte marker S-100
(Pompolo and Harley, 2001). Collectively, this indicates that SOX9
is intimately involved in directing the fate neural crest and neural
tube precursor cells toward a glial cell phenotype. As mentioned
above, overexpression of SOX9 in the fetal gonads leads to XX sex
reversal, and these XX males exhibit the same degree of aggression
and the same pattern of mating behavior as their XY male counter-
parts (Canastar et al., 2008). This demonstrates that SOX9 makes
an important contribution to the development of male-speciﬁc
behaviors.
The transcription factor Sox11 and one of its binding partners
required for transactivation of downstream target genes Brn1 also
are upregulated during the late embryonic and neonatal periods
of rat brain development (Kim et al., 2008). The expression of
SOX11 and other SOX proteins like SOX2 and SOX4 is seen at
E8.5 of murine in utero development, around the time of neuru-
lation (Cheung et al., 2000). By E12, strong expression is observed
in the sub-ventricular zone, where precursor cells have begun to
differentiate (Cheung et al., 2000). The level of brain expression
of Sox11 observed at E15.5–17.5 are ∼10× higher than at PND
7, and over 100× above that observed in the adult – with the
highest levels of expression found in the cortex and other areas
enriched with neuronal progenitors and immature neurons (Kim
et al., 2008;Han et al., 2009; Ling et al., 2009). This expression tem-
porally coincides with the heightened expression of components
of the Wnt/β-catenin, p53, and tight junction signaling pathways
(Ling et al., 2009). It is also observed in differentiating and prolif-
erating P19 embryonic carcinoma cells (Ling et al., 2009). Sox11
expression in cultured dorsal root ganglia neurons and Neuro2a
neuroblastoma cells elicits neurite outgrowth and differentiation
(Jankowski et al., 2006). Conversely, knockdown of Sox11 expres-
sion in these cells reduces neurite outgrowth, and causes increased
expression of the pro-apoptotic gene BNIP3 as well as decreased
expression of the anti-apoptotic gene TANK and the gene encod-
ing the actin organizing protein Arpc3 that is involved in axon
growth (Jankowski et al., 2006). Thus, it is clear that the CNS is
an organ that, much like the cells and tissues of the gonads, repro-
ductive tract and external genitalia, is targeted by the SRY gene
product TDF, MIS, testicular hormones, neurosteroids, and also
possibly SOX proteins during the in utero and neonatal periods
for the development of male patterns of behavior.
CONTRIBUTION, ADVANTAGES, AND LIMITATIONS OF
ANIMAL MODELS IN THE STUDY OF PSYCHIATRIC
DISORDERS AND DRUG ABUSE
The most accurate way to study psychiatric disorders and drug
abuse would be using patients, but obviously this is not possi-
ble for ethical and practical reasons. Fortunately, animal models
allow us to study molecular, protein and tissue changes, as well as
behavioral alterations, that shed light on the origins and patho-
physiologic sequelae of these diseases. They also provide high-
value information about the effectiveness of medicines and the
possible development and testing of treatments. As with differ-
ent research tools, animal models have their pros and cons. One
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of the advantages of animal models is that the experiments per-
formed on them are conducted under well-controlled conditions
(Viveros et al., 2011b); with the expressed purpose of minimizing
the inherent variability. The great majority of animal models used
for psychiatric disorders and drug addiction involve rats and mice.
The advantages of using these two species are that we have a very
goodknowledgeof their anatomy,physiology,biochemistry,genet-
ics, and behavior. Moreover, in recent years their genomes have
been sequenced, which give us the opportunity to construct KO
animals, analyze single-nucleotide polymorphisms (SNPs), target
speciﬁc sequences within disease-associated alleles, and ﬁnally to
compare their genomes with that of the human genome.
The major limitation of animal models for psychiatric disor-
ders and drug dependence is that it is impossible to reproduce the
syndrome in its entirety (Viveros et al., 2011b), because many of
the symptoms used to diagnose psychiatric disorders in patients
(e.g.,hallucinations, suicide feelings, sadness,or guilt) are uniquely
human. Another difﬁculty of these models is that despite the sim-
ilarities between rodent brain and human brain, there are still
some differences in functions and behaviors that must be taken
into account in order to avoid misinterpreting the results. Thus,
the generation of reliable animal models to study neuropsychiatric
disorders continues to present a challenge to modern biomedical
research (see Nestler and Hyman, 2010 for review).
INSIGHTS ON DRUG ABUSE AND DEPENDENCE FROM EXPERIMENTAL
MODELS
The most common animal model or “standard tool” to study drug
addiction is the drug self-administration paradigm that normally
entails training an animal to self-administer a drug (intravenous or
oral administration) by pressing a bar (Lynch et al., 2010). Along
with other standardized behavioral assays (see Table 1), they col-
lectively provide useful information on receptor pharmacology,
neurotoxic lesions, or hormonal effects (Roberts et al., 2007).
As explained in the introduction, drug abuse, and dependence
are sex-dependent and also present a general pattern – with men
presenting higher rates of dependence and abuse andwomenbeing
more vulnerable to drug negative effects. However, there are some
particularities for the most commonly abused drugs.
Alcohol
Studies of alcohol abuse in human and animal models present a
lack of correlation that is frequently explained by educational and
sociocultural factors. It is known that women are less prone to
develop alcohol abuse (Kalaydjian et al., 2009) whereas females
mice present a higher degree of alcohol consumption than males
(Lancaster et al., 1996). Theuse of the FCGmousemodel described
above has enabled Barker et al. (2010) to determine that sex chro-
mosome complement affects habit formation depending on the
reinforcer (possibly explaining the differences between men and
women for at least some drugs or palatable foods), and conﬁrm
that females have greater free alcohol consumption. This suggests
that there are differences in motivation to work for alcohol or
disparities in the ability to track reinforcer availability.
Psychostimulants
Since the ﬁrst preclinical research on cocaine sensitization was
published, sex differences in response to the drug in adult rats
have been noted. Many studies with animals have reported that
females are more responsive, sensitize more readily than males
to cocaine, and self-administer greater quantities of cocaine than
males (Dow-Edwards, 2010). Other results showed that male and
gonadectomized female rats had enhanced behavioral responses
and brain metabolic activity following repeated cocaine admin-
istration, while changes in intact females were substantially less
prominent (Dow-Edwards et al., 2005). These differences have
been attributed historically to social or hormonal factors. Indeed
it has been shown that gonadal steroid hormones exert orga-
nizational and activational effects within the CNS (Dluzen and
McDermott, 2006), both of which could interact with cocaine
abuse. However, recent studies involving sex chromosome com-
plement suggest that genetic factors are also decisive in addiction
(Barker et al., 2010). As described above these differences stem
from disparate doses of genes residing on the X chromosome.
Often the phenotypes differentiated by direct sex chromosome
effects are also inﬂuenced by gonadal hormones, so understand-
ing the interaction of sex-speciﬁc hormonal and sex chromosomal
effects is an urgent need (McCarthy andArnold, 2011). The effects
of sex hormones and sex chromosomes have been investigated in
behavioral,molecular, and immunohistochemical studies, but fur-
ther evidence is needed, for example,with neuroimaging tools that
show sex-dependent cocaine-induced changes in brain function
(Andersen et al., 2012).
Marijuana
Preclinical studies have recently identiﬁed many of the factors that
determine vulnerability to cannabis dependence. These include
genetic and biological factors, animal strain differences (Deiana
Table 1 | Standardized animal models to study different aspects of drug addiction.
Human behavior Animal model Reference
Drug addiction Self-administration paradigm Pickens et al. (1978)
Vulnerability to drug abuse Models of initiation or acquisition phase Campbell and Carroll (2000)
Transition from control to compulsive use Progressive ratio schedule Roberts et al. (2007)
Relapse to drug abuse Reinstatement paradigm Katz and Higgins (2003)
Rewarding effects of drugs Conditioned place preference Lynch et al. (2010)
Subjective effects of drugs (abuse liability) Drug discrimination paradigm Holtzman (1990), Balster (1991)
Physical dependence Substitution procedures and primary dependence procedures Lynch et al. (2010)
Inﬂuence of genetics Four-core genotype mice Arnold and Chen (2009)
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et al., 2007), as well as sex and ovarian hormones (Deiana et al.,
2007; Fattore et al., 2007; Fattore and Fratta, 2010). Animal mod-
els suggest that there are sex-dependent differences in developing
and maintaining cannabinoid self-administration (SA) behavior.
Fattore et al. (2007) have shown that females acquire cannabi-
noid agonist intake at a higher rate than males, and that they are
more susceptible to cannabinoid-induced rewarding effects and
more reactive than males to saline substitution during the extinc-
tion period. In addition, the chronic use of tetrahydrocannabinol
(THC) in adolescent females (but notmales) subsequently induces
depressive-like behaviors in adulthood (Rubino et al., 2008).Other
preclinical studies show that sub-chronic adolescent exposure to
CP (a CB1 receptor agonist) induces sex-dependent, long-term
deleterious effects on memory function. Mateos et al. (2010) have
shown that the detrimental effects of chronic cannabinoid use
are sex-dependent, and that the diverse aspects of memory func-
tion may be differentially affected in each sex. CP also produces
sexually dimorphic effects in other behaviors like motor activity
(decreased in treated females), exploratory parameters (increased
in treated females), and anxiety-like behavior (decreased in treated
females; Biscaia et al., 2003; Llorente-Berzal et al., 2011). Cannabi-
noid treatment also increases the number of GFAP (a marker
of astrocytes)-positive cells in the dentate gyrus of males but
not females, and this was associated with decreased CB1 recep-
tor immunoreactivity in CP-treated males (López-Gallardo et al.,
2011). Many of the long-term cognitive and behavioral effects of
adolescent cannabinoid treatment might be related to less synap-
tic contacts in the hippocampus (Rubino et al., 2008), and it is
tempting to speculate that this disparate synaptic effect is sex-
dependent and occurs in parallel with the differential behavioral
impact (Viveros et al., 2011b). Early cannabinoid consumption
alters the endocannabinoid system, which is an important com-
ponent of reward system that may predispose individuals to the
misuse of addictive drugs later in life as proposed in the “gateway
hypothesis” (Kandel et al., 2006). Adolescent treatment with CP
exerts sex-dependent effects on morphine reinforcement in adult-
hood. CP-treated males show a higher SA rate of morphine under
a ﬁxed-ratio schedule and decreasedmu-opioid receptor function-
ality in the nucleus accumbens (NAc) shell, whereas females are
not affected (Biscaia et al., 2008). This same effect was reported by
Higuera-Matas et al. (2008) – female rats exposed to chronic CP
treatment during puberty showed higher adult cocaine-SA and a
higher reduction in anxiety when compared with males.
ANIMAL MODELS OF PSYCHIATRIC DISORDERS
As explained at the beginning of this section, although animal
models do not reproduce every symptom of psychiatric disorders,
they allow us to mimic some biological and behavioral changes.
We will focus on experimental models based on the neurodevelop-
mental theory and the related“three-hit”hypothesis,where genetic
factors, early life events and later life events should be consid-
ered as a “hit” separately. The neurodevelopmental theory states
that abnormalities and disturbances during brain development,
caused by both genetic and environmental factors, are likely to
affect behavior later in life and lead to the emergence of psychiatric
disorders such as schizophrenia, BP, or autism (Rehn and Rees,
2005; Fatemi and Folsom, 2009). Based on this theory, Maynard
et al. (2001) developed the “two-hit” hypothesis of schizophrenia
that could also be applied to other neurodevelopmental psychiatric
disorders that begin in childhood or adolescence (Sanches et al.,
2008). According to this hypothesis, genetic, and early environ-
mental factors (ﬁrst-hit) disrupt CNS development and together
act as a vulnerability factor that produces a long-term suscepti-
bility to an additional adverse event (second-hit), usually around
puberty, that then precipitates the onset of schizophrenic symp-
toms (see Fernández-Espejo et al., 2009 for review). Other studies
propose the three-hit hypothesis. The effects of these “hits” appear
to be sexually dimorphic. However, there is very scarce infor-
mation regarding sex differences in these models (Malone et al.,
2010; Llorente et al., 2011; Llorente-Berzal et al., 2011). It would
be especially interesting to include the factor “sex” in the so-
called “match-mismatch hypothesis” that extends the concept of
the neurodevelopmental theory by proposing that many diseases
characterized by developmental risk factors reﬂect a mismatch
between early environment and later environment. Thus, some
human psychiatric disorders would appear when the physiologic,
homeostatic, and stress systems do not adapt (i.e.,match) with the
current adult environment. In this context, sexually dimorphisms
could be due to differences in adaptive plasticity and to the abil-
ity to respond properly to new environment conditions (Schmidt,
2011).
(1) “Early neurodevelopmental models” focus on genetic and envi-
ronmental factors during the critical prenatal and perina-
tal period that produce brain developmental abnormalities,
thereby allowing the study of the long-term physiological and
behavioral consequences of early life stress. Thepredisposition
toward sex-biased disorders has been associated with stress-
related fetal antecedents (Pardo and Eberhart, 2007; Mueller
and Bale, 2008). In many preclinical studies, prenatal stress
(PS) has been shown to produce alterations in the HPA axis
of the offspring that may give rise to anxiety, depressive-like
behaviors, and cognitive deﬁcits, all of which are endopheno-
types associated with neuropsychiatric disease (Dunn et al.,
2011). PS inﬂuences development through reprogramming
and epigenetic processes;modifying keydeterminants of stress
responses such as the expression of corticotrophin releas-
ing factor (CRF) and glucocorticoid receptors (GR) by DNA
methylation. As the brain is not completely developed dur-
ing this period of early stress, it has been hypothesized
that sex-speciﬁc changes in fetal development and long-term
stress sensitivity may occur through interactions between the
maternal environment, placental changes, and epigenetic pro-
gramming of the embryo (Mueller and Bale, 2008; Dunn
et al., 2011). Indeed, the placenta gene pattern differs in
males and females; with lower expression of DNMT1, the
enzyme responsible for methylation maintenance, observed
in males than in females. Male offspring exposed to PS present
altered stress coping responses and depression-like behaviors,
whereas females are not affected (Mueller and Bale, 2008).
This is in line with clinical studies showing a sex-dependent
risk to develop schizophrenia in males due to stress early in
pregnancy. Furthermore,Morgan andBale (2011) have shown
that these abnormalities can persist in subsequent generations
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by transmitting a stress-sensitive phenotype, suggesting the
possibility of heritable epigenetic mechanisms.
Another interesting animal model of early life stress with
which we have been working during the past several years
consists of submitting rats to a single 24-h episode of mater-
nal deprivation (MD) at PND 9. As adults, these MD rats
exhibit abnormalities resembling psychotic-like symptoms,
including disturbances in pre-pulse inhibition, latent inhi-
bition, auditory sensory gating, and startle habituation. Pos-
sible underlying neurochemical correlates in adult MD ani-
mals include reduced hippocampal levels of neuropeptide Y
(NPY), calcitonin-gene-related peptide, polysialylated neural
cell adhesion molecule (NCAM), and brain-derived neu-
rotrophic factor (BDNF),aswell as a decrease inNMDArecep-
tor subunits NR-2A and NR-2B (see for review Ellenbroek
and Riva, 2003; Ellenbroek et al., 2004). In addition, adoles-
centMDrats showed depressive-like behaviors (Llorente et al.,
2007), as well as a trend toward increased impulsivity (Marco
et al., 2007). According to the neurodevelopmental hypoth-
esis, it has been hypothesized that at least certain behavioral
abnormalities observed in MD animals might be related to
altered neurodevelopmental processes. Immunohistochemi-
cal results appeared to support this hypothesis, as it has been
shown that MD-induced neuronal degeneration increased
the number of GFAP-positive cells in the hippocampus and
cerebellar cortex of neonatal rats, and altered the hippocam-
pal endocannabinoid system. Interestingly, these effects were
oftenmoremarked inmales (Llorente et al., 2007; Suarez et al.,
2009, 2010; Viveros et al., 2009). These results are in line with
some epidemiological studies showing a higher degree of dys-
functional brain activity and neuroanatomy in SZ men (see
Schizophrenia).
(2) “Late neurodevelopmental models” suggest that even in the
absence of these early abnormalities in brain development,
later life events could lead to the emergence of psychiatric
disorders. These “late models” focus on adolescence that is a
period of unique vulnerability for persistent effects of chronic
stress. Experimental animal studies support that adolescence
is a critical period in development, a“windowof vulnerability”
with respect to the onset of major neuropsychiatric disorders.
Adverse events (e.g., drug exposure), during this period may
serve a risk factor for suffering psychotic symptoms in adult-
hood (Adriani and Laviola, 2004; Fernández-Espejo et al.,
2009). Although the effects of adolescent stress are not as
well characterized as early postnatal stress models, the avail-
able literature on late neurodevelopmental models suggests
that exposure to chronic stress during adolescence can be
more detrimental than similar exposure in adulthood (Bourke
and Neigh, 2011). Furthermore, studies with rats (Doremus-
Fitzwater et al., 2009) and mice (Adriani and Laviola, 2000;
Laviola et al., 2002) show that stress during adolescence mod-
iﬁes the reactivity of the HPA axis, which is disrupted in
many psychiatric disorders (Dunn et al., 2011). The work of
Bourke andNeigh (2011) demonstrates a sustained increase in
depressive-like behaviors in female but notmale rats following
chronic adolescent stress. The results of this model contrast
with those obtained from early developmental models where
males are more affected by stress; thus suggesting that the
sensitive periods also vary between males and females. Tem-
poral differences in HPA axis development between males and
females (Pignatelli et al., 2006) may account for prolonged
sex-dependent effects induced by adolescent stress on physi-
ology and behavior (Bourke and Neigh, 2011). Results from
late development animal models are in line with clinical stud-
ies showing that girls react more strongly to stressful events
than boys, and experience greater depressive symptomatology
(Hankin et al., 2007).
Unfortunately, there is limited animal research data that
addresses sex differences in PTSD. The animal model of PTSD
that characterizes behavioral patterns in response to a stressor (i.e.,
predator scent stress) was used to investigate sex differences in rats
(Mazor et al., 2009).Analyses did not ﬁnd differences in prevalence
rates of PTSD-like behaviors – although baseline levels of anxiety
were higher for females and their peak levels of response to stress
were lower (Mazor et al., 2009). Sex differences in stress response,
endocrinology, and morphology at baseline have also been widely
reported in the animal literature. Females generally demonstrate
higher plasma and adrenal corticosterone at rest (Iwasaki-Sekin
et al., 2009) that are believed to result from the effects of estro-
gen. Estrus cycle ﬂuctuations in estrogens can signiﬁcantly affect
the morphology of the hippocampus in female rats, with higher
estrogen resulting in increased dendritic spine density (Leranth
et al., 2003). This is in line with the dimorphisms found in adap-
tive plasticity and the ability to cope and adapt to stressors, thus
potentially inﬂuencing vulnerability to stress-related disease and
disorder.
Furthermore, many examples from the literature document
sex-related differences in behavior and neurobiology at baseline
and in response to stress. In contrast with epidemiological pat-
terns in humans, female rodents are more resilient following acute
and chronic stress,whereasmales aremore vulnerable. This inverse
relationship may in part reﬂect baseline differences in glucocorti-
coids. Female rodents have higher basal levels of corticosterone
and more adaptive stress responses, whereas men have higher
basal cortisol levels. These ﬁndings may imply that higher levels
of cortisol could be protective against the development of PTSD.
This hypothesis is consistent with studies showing an association
between the development of PTSD and low peri-traumatic corti-
sol levels (McFarlane et al., 2011), which has been proposed as a
pretraumatic risk factor for PTSDand stress-relatedpsychopathol-
ogy (Yehuda et al., 2010). Regardless, the development of PTSD
following trauma requires further investigations to help recon-
cile the contradictory ﬁndings of sex differences in animal versus
human research. These will undoubtedly help elucidate the true
biological indicators of risk or pathophysiology,which will inform
efforts at prophylaxis and intervention.
SEX DIFFERENCES AND THE ADOLESCENT BRAIN IN
HUMANS
As described above, shaping of the mammalian brain by sex hor-
mones begins in utero (see Thornton et al., 2009 for a review of
the organizational effects of androgens in non-human primates).
Sexual dimorphism in the human brain, as assessed in vivo with
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magnetic resonance imaging (MRI), is present at birth. For exam-
ple, the brain size of male neonates is about 6% larger than that
of female neonates (Gilmore et al., 2007). This might be, at least
in part, related to prenatal exposure to androgens; girls with male
co-twins have slightly larger brains than girls with female co-twins
(Peper et al., 2009). As reviewed recently, sex differences in global
and regional brain volumes vary in their magnitude over the lifes-
pan, with values of the effect size (Cohen’s d) ranging between 0.5
and 1.6 for global brain size and around 0.2 for regional volumes
adjusted for brain size (Paus, 2010a).
Here, we will focus on sex differences in brain structure during
human adolescence. A surge of sex hormones during puberty rep-
resents one hallmark of adolescence. But as pointed out by others,
adolescence does not equal puberty: “puberty refers to the activa-
tion of the hypothalamic-pituitary-gonadal axis that culminates in
gonadal maturation” while “adolescence refers to the maturation
of adult social and cognitive behaviors” (Sisk and Foster, 2004).
When interpreting sex differences in brain structure (and func-
tion) during adolescence, we should keep in mind the possibility
that they reﬂect rather than drive sex differences in behavior. In
other words, they may reﬂect experience-based changes in brain
structure akin to those seen in other contexts (e.g., Draganski
et al., 2004; Driemeyer et al., 2008). This possibility is of particular
importance during this period of human development, which is
characterized by signiﬁcant changes in the daily life of an adoles-
cent (over those of a child), such as the need to establish new social
hierarchies in the context of (large) peer groups.
As pointed out above,MRI is the tool of choice for in vivo stud-
ies of developmental changes in the structure (and function) of
the human brain (see Table 2 for an overview). The following are
the most common MR sequences used in studies of brain devel-
opment. High resolution, isotropic T1-weighted (T1W) images
provide excellent contrast between gray and white matter and, as
such, arewell suited formorphometric studies of the humanbrain;
T1W images yield a large number of outcome measures, includ-
ing volumes of different brain compartments (e.g., gray and white
matter volumes) and brain regions (e.g., volume of the hippocam-
pus), as well as features of the cerebral cortex (e.g., thickness and
folding). Diffusion Tensor Imaging (DTI) enables a virtual dissec-
tion of key white matter tracts (i.e., anatomic connectivity) that
are necessary for communication amongst brain regions, as well as
the assessment of micro-structural features (fractional anisotropy
and mean diffusivity) that depend on axon packing, axon caliber,
and myelination. Magnetization Transfer Ratio (MTR) provides
an indirect index of the regional content of myelin. Functional
MRI allows investigators to measure the brain response associ-
ated with the processing of various stimuli, cognitive operations,
or emotional states; this measure is based on the regional cou-
pling between brain activity and vasodilation. Readers interested
in more detail information about these techniques are referred to
other publications (e.g., Paus, 2010b).
These techniques have been employed in various combinations
in a number of large-scale studies of brain development, includ-
ing (1) a cohort established in the Child Psychiatry Branch of
the National Institutes of Mental Health (NIMH-CHPB); (2) NIH
Pediatric MRI Database (NIH-PD; Evans and Brain Development
Cooperative Group, 2006); (3) the Saguenay Youth Study (SYS;
Table 2 | Example of a 60-min MR protocol enabling one to
characterize structural and functional properties of the human brain.
MRI sequence Time (min) Structure and physiology
T1-weighted 10 Volumes, thickness, folding,
shape, tissue density
T2-weighted 4 White matter hyperintensities
(number, volume, location)
Diffusion tensor
imaging
12 Fractional anisotropy, mean
diffusivity, track delineation
Magnetization transfer 8 Myelination index
Arterial spin labeling 5 Perfusion
Resting state functional 8 Spontaneous cerebral networks;
functional connectivity
Paradigm-based
functional
6–10 Brain response associated with
speciﬁc stimuli/tasks; functional
connectivity
Pausova et al., 2007); and (4) the Imagen Study (Schumann et al.,
2010). As described in more detail elsewhere (Paus, 2010c), these
studies of typically developing children and adolescents have col-
lected a wealth of data on the developmental trajectories of gray
and white matter growth (NIMH-CHPB, NIH-PD, SYS), as well
as on the functional engagement of brain networks during face
processing, response inhibition, and reward (IMAGEN). Two of
the studies (SYS, IMAGEN) are beginning to work on the iden-
tiﬁcation of genes associated with various brain phenotypes in a
genome-wide manner. Next, we will summarize two sets of ﬁnd-
ings obtained in the SYS. The ﬁrst concerns sexual dimorphism in
age-related changes in the volumes of white and gray matter, and
the role of the androgen-receptor gene (AR) in moderating the
inﬂuence of testosterone on these volumes in male adolescents.
The second set describes apparent differences in the vulnerability
of female (versus male) offspring to prenatal exposure to maternal
cigarette smoking vis-à-vis several brain phenotypes.
As shown in Figure 1, both absolute and relative (brain size
adjusted) volumes of white matter increase with age more steeply
in male versus female adolescents (Perrin et al., 2008). In male
adolescents, we also observed a moderating effect of a functional
polymorphism in AR on the relationship between plasma levels of
bioavailable testosterone and WM volume; this relationship was
strong in boys with an “efﬁcient” version of AR and weak in boys
with an “inefﬁcient” version of AR (Perrin et al., 2008). We also
found that MTR, an indirect index of myelination, decreased with
age in the white matter of male adolescents, suggesting that the
observed testosterone-related changes might reﬂect an increase in
axonal caliber instead (Perrin et al., 2008).We concluded that, dur-
ing male adolescence, there might be a disproportionate growth
of the axon and myelin sheath that would result in possible sex
differences in the g ratio (deﬁned as the ratio between axon cal-
iber and ﬁber diameter). Next, we predicted that white matter
regions occupied by large-diameter axons would have a lower
concentration of myelin (Paus and Toro, 2009). We conﬁrmed
this prediction indirectly by observing age-related changes in the
“whiteness” of the large-axon cortico-spinal tract (Herve et al.,
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FIGURE 1 | Age-related increase in absolute (top) and relative (brain size adjusted) volume of white matter in male and female adolescents. Reprinted
with permission from Paus andToro (2009).
2009) and, more directly, by showing that this ﬁber tract, assessed
at the level of the internal capsule, has lower MTR values and
longer T2 relaxation times than the adjacent (smaller axon) white
matter (Herve et al., 2011). We speculated that the presumed
testosterone-induced changes in axonal diameter duringmale ado-
lescence increase the probability of a suboptimal g ratio in the
large-diameter ﬁbers and, in turn, decrease conduction velocity in
these ﬁbers, aswell as perturb axonal transport in these axons (Paus
and Toro, 2009). Such disturbances might interfere with the tim-
ing of inter-regional communication and contribute to the known
earlier onset of schizophrenia in men versus women (Hafner et al.,
1998).
The above age- and testosterone-related changes in white mat-
ter are mirrored in gray matter. As can be seen in Figure 2, regional
age-related decreases in cortical gray matter are more pronounced
in male versus female adolescents. Furthermore, the negative rela-
tionship between plasma levels of bioavailable testosterone and
cortical gray matter is more pronounced in male adolescents
with an “efﬁcient” AR versus those with an “inefﬁcient” AR (Paus
et al., 2010). Although the neurobiological underpinnings of these
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FIGURE 2 | Age-related decreases in cortical gray matter in male (top)
and female (bottom) adolescents. Reprinted with permission from Paus
andToro (2009).
age-related decreases in graymatter are unknown, they are unlikely
to be related to synaptic pruning as have been commonly suggested
(see Paus et al., 2008a for a discussion of this topic). At present,
we are testing the possibility that these changes in gray matter
might be also associated with testosterone-associated changes in
intra-cortical axons.
The SYS has been designed to evaluate the possible long-term
consequences of prenatal exposure to maternal cigarette smok-
ing on the adolescent brain (Pausova et al., 2007). Given the
limitations of epidemiological studies in examining associations
between exposures andoutcomes,we are,of course,unable to draw
any causal conclusions from simply observing such associations.
Nonetheless, results presented below raise interesting questions
about the role of sex in moderating individuals’ vulnerability to an
adverse intrauterine environment. When we compared “exposed”
and “non-exposed” adolescents, the latter having been matched
to the former by maternal education to minimize possible dif-
ferences in socio-economic status, we observed that the exposed
(versus non-exposed) adolescents had a thinner orbitofrontal cor-
tex (Toro et al., 2008) and smaller corpus callosum (Paus et al.,
2008b). Importantly, these effects appear more pronounced in
female adolescents, especially in the case of the corpus callo-
sum. More recently, we have carried out the ﬁrst genome-wide
scan for genes associated with brain size and identiﬁed KCTD8
at genome-wide signiﬁcance in the sample of female (but not
male) adolescents (Paus et al., 2011). When testing the most sig-
niﬁcant SNP of this gene (rs716890, p = 5.40E−09) vis-à-vis the
total cortical area, we discovered an interaction of this polymor-
phism with prenatal exposure to maternal cigarette smoking: this
SNP explained 21% of the variance in cortical area in the exposed
female adolescents and only 4.5% (not signiﬁcant) in the non-
exposed females (Paus et al., 2011).We speculated that the absence
of an interaction between KCTD8 genotype and exposure with
respect to the area (and folding) of the cerebral cortex in male
adolescents might be related to a protective effect of androgens
in utero. These two sets of ﬁndings from the SYS illustrate the
possible effects of sex hormones on the developing brain, effects
that might either increase (testosterone, AR, and white matter)
or decrease (testosterone, KCTD8, and cortical area) individuals’
vulnerability to brain disorders.
SEXUAL DIMORPHISMS IN PSYCHIATRIC DISORDERS AND
DRUG ABUSE
Clinical observations and epidemiological data reveal important
sex differences in the prevalence and symptomatology of various
mental health problems and drug abuse. For example, the lifetime
prevalence of major depressive disorder (MDD), as well as anxiety
disorders combined, in women is approximately twice that of men
(American Psychiatry Association (APA), 1994; Blazer et al., 1994;
Scott, 2006; Smith et al., 2008), while the onset of schizophrenia
is typically 3–5 years earlier and the course of the illness is more
severe in men than in women (Flor-Henry, 1985; Hafner et al.,
1998a; McGrath, 2007; Keshavan et al., 2008; McGrath and Susser,
2009). Interestingly,when it comes to the neurodevelopmental dis-
orders, diagnosed in children, such as autism and attention-deﬁcit
hyperactivity disorder, the situation is reversed (i.e., they are more
commonly diagnosed in boys). Concerning drug dependence and
abuse, the general pattern of sex differences is thatmenhave higher
rates of dependence and drug abuse whereas women progress to
dependence faster and are more vulnerable to the negatives effects
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of drugs. This is true for almost every drug, but some speciﬁc
aspects for each will be explained below.
Overall, it is recognized that factors that interfere with the
inﬂuence of sex hormones on the developing brain may perma-
nently inﬂuence not only later behavior (e.g., cognition, emotion,
empathy, aggression, etc.), but may also carry the risk of neu-
ropsychiatric disorders. For example, the “extreme-male brain”
hypothesis of autism proposes that the condition represents an
extreme variant of male-typical neurocognitive proﬁle (Baron-
Cohen, 2009). Speciﬁcally, in the general population males tend
to score higher on systemizing (deﬁned as the tendency to analyze
the rules of the system and predict its behavior), while females
are better at empathizing (deﬁned as the tendency to infer mental
and emotional states of others and respond accordingly; a critical
component of social cognition), but overall there is a signiﬁcant
overlap between the two sexes. In comparison, in autism-spectrum
disorders the discrepancy between systemizing and empathizing
is skewed in a male-typical direction and this proﬁle may be a
result of exposure to elevated levels of testosterone during fetal
neurodevelopment (Baron-Cohen, 2002).
Schizophrenia is also considered to be a neurodevelopmen-
tal disorder with origins during second and third trimester of
the fetal development (Szulc et al., 2005; Powell, 2010; Kesha-
van et al., 2011), which coincides with sexual differentiation of
the brain. Interestingly, it has been recently suggested that autism
and psychosis represent two extremes on a cognitive spectrum,
with social cognition being underdeveloped (gaze-avoidance,
“literal-mindedness,” etc.) in autistic-spectrum disorders and
over-developed (“hyper-mentalizing,”over-interpretationof men-
tal states and intentions etc.) in psychotic-spectrum disorders (the
most severe being schizophrenia; Crespi and Badcock, 2008). It
has been further proposed that as autism involves traits repre-
sentative of an “extreme-male brain,” psychotic-spectrum disor-
ders may be characterized by a “female-typical” neuroanatomy,
cognition, and behaviors (Crespi and Badcock, 2008). However,
while the “extreme-male brain” theory of autism works rela-
tively well with males, it is harder to apply to females affected
with autism-spectrum disorders (Barbeau et al., 2009). Similarly,
while it is likely that males affected with psychosis may be de-
masculinized/feminized, the situationmaybe different for females,
as our data in chronic schizophrenia patients as well as the avail-
able literature (reviewed below) imply. It should be noted that
the theories discussed in this section are not universally accepted
and there are discordant data and views; nevertheless they provide
interesting examples of how sex steroid hormones may interact
with and contribute to psychiatric symptom.
For the purpose of the present review we narrowed our focus
to sex differences in primarily adult psychopathologies, includ-
ing mood disorders, schizophrenia, autism, and PTSD as well as
drug dependence, as all of them present with striking sexually
dimorphic features in the brain and clinical expression.
SCHIZOPHRENIA
Schizophrenia (SZ) remains one of the most complex and debil-
itating disorders of the CNS. Its complexity is reﬂected in the
heterogeneous clinical presentation with symptoms ranging from
hallucinations and delusions, disorganized speech and behavior,
to ﬂat affect and lack of motivation (Rund and Borg, 1999;
Green, 2006). The seriousness of SZ lies in the fact that its life-
time prevalence is approximately 1%, it begins typically during
late adolescence or early adulthood, often leads to a social and
economic impoverishment and a great distress for both patients
and their families, and ends in suicide in about 10–15% of cases
(50% of patients will attempt suicide at some point of their ill-
ness; Andreasen and Carpenter, 1993; Saha et al., 2007). The most
recent studies suggest that the rate of 1% is not universal and
while it is a good estimate in the western society, the prevalence
of schizophrenia is lower in the developing countries, but higher
in migrant groups than in native-born populations (Saha et al.,
2005). The genetic basis of schizophrenia has been well docu-
mented in several twin and adoption studies (Kendler and Diehl,
1993; McGufﬁn et al., 1995), however the fact that approximately
50% of monozygotic twins are discordant for schizophrenia, indi-
cates the importance of environmental factors (Takei et al., 1995;
Mortensen et al., 1999). The etiology of SZ remains obscure.
Sex differences in clinical expression
The lifetime risk to develop schizophrenia is higher in young men,
while beyond the age of 40, the risk is higher in women (Leung
and Chue, 2000). This effect contributes to the earlier (approx-
imately 3–5 years) age-at-onset of schizophrenia in men relative
to women (Jablenksy, 1992; Hafner et al., 1998). Moreover, there
is evidence that compared with women, men exhibit poorer pre-
morbid functioning and greater IQ deﬁcits (Flor-Henry, 1985).
Finally, sex differences in the clinical expression of the disorder
have been documented with men exhibiting on average more pro-
nounced negative symptoms such as social withdrawal, blunted
affect, poverty of speech, and abolition (Kay et al., 1986; Ring
et al., 1991; Schultz et al., 1997), while women displaying more
affective symptoms such as dysphoria, impulsivity, inappropriate
affect, and more atypical psychotic symptoms (Shtasel et al., 1992;
Andia et al., 1995; Szymanski et al., 1995).
Hormonal implications
Numerous epidemiological, neurochemical, and clinical studies
imply a protective role of estrogen in schizophrenia (Seeman,1996,
1997; Grigoriadis and Seeman, 2002). For example, inverse rela-
tionships have been found between menarche (i.e., age of ﬁrst
period in girls) and ages at the ﬁrst psychotic symptoms and the
ﬁrst hospitalization (Cohen et al., 1999). Clinical reports show a
correlation between estrogen plasma concentration and intensity
of psychotic symptoms. During pregnancy, when estrogen levels
are high, low rates of relapse have been observed in women with
schizophrenia, while exacerbation of symptoms usually occurs
postpartum (Chang and Renshaw, 1986; Kendell et al., 1987). In a
similar fashion, symptoms have been reported to ﬂuctuate across
the menstrual cycle in women with schizophrenia, with clinical
deterioration during follicular phase (low estrogen) and amelio-
ration during mid-luteal phase (high estrogen; Hallonquist et al.,
1993; Gattaz et al., 1994; Hendrick et al., 1996; Bergemann et al.,
2007).
Although to a lesser degree than estrogen, testosterone has also
been implicated in the pathophysiology of schizophrenia (Moffat,
2005; Mendrek, 2007). Early studies reported delayed puberty and
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low testosterone levels in males with schizophrenia (Kline et al.,
1968), whereas more recent investigations have demonstrated an
inverse relationship between the plasma level of testosterone and
the severity of negative symptoms in male patients (Shirayama
et al., 2002; Akhondzadeh et al., 2006; Ko et al., 2007).
Neuroanatomical data
Consistently with the direction of normal sexual dimorphism,
neuroimaging, and post-mortem studies in SZ have shown that
men have larger ventricles (Andreasen et al., 1990), and smaller
overall frontal and temporal lobe volumes relative to women
(Andreasen et al., 1994;Reite et al., 1997;Gur et al., 2000), although
not all the studies have found this effect (Flaum et al., 1995;
Lauriello et al., 1997). Goldstein and associates have found an
interesting effect in the cingulate gyrus. Speciﬁcally, while the
structure is typically larger in healthy women than in men (Paus
et al., 1996; Goldstein et al., 2001), in SZ patients the opposite pat-
tern was observed (Goldstein et al., 2002). These ﬁndings were
subsequently replicated in SZ patients (Takahashi et al., 2003)
and in individuals with schizotypal personality disorder (Taka-
hashi et al., 2004). An equally interesting reversal of normal sexual
dimorphism has been reported by Gur et al. (2002, 2004) in two
other structures: orbitofrontal cortex and amygdala. In a different
study, Frazier et al. (2008) reported that early onset SZ boys had
smaller amygdala relative to girls, while the opposite pattern has
been found in the general population. Preliminary results from
our laboratory also imply a disturbed normal sexual dimorphism
in brain structure in SZ. Thus, using the voxel-based morphome-
try (VBM) we have found that both male and female patients had
signiﬁcantly diminished prefrontal gray matter density compared
with healthy controls, but only male patients showed preserved
gray matter in the orbital surface of the inferior frontal cortex.
In the parietal cortex, on the other hand, while again both male
and female patients had signiﬁcantly lower gray matter density
compared to controls, only women patients had more preserved
parietal cortex in the supramarginal gyrus andprecuneus (Jiménez
et al., 2008; Mancini-Marïe et al., 2008a,b; Figure 3). A recent
study by Irle et al. (2011) suggests that the hippocampal volume
is reduced in male but not in female patients at the onset of SZ
(relative to the same-sex controls), but with progressing years SZ
women “catch up” with men. This study emphasizes the impor-
tance of investigating neuroanatomical changes in a longitudinal
manner in both sexes.
Functional neuroimaging studies
Despite numerous neuroimaging studies of cognitive function and
emotion processing in schizophrenia, sex differences have not typ-
ically been examined. We have addressed this issue in a series of
studies. Our initial investigation consisted of the re-analysis of
already existing fMRI data sets collected in schizophrenia patients
during processing of negative emotions. We have found a very
different pattern of cerebral activations between men and women
patients, but the absence of a healthy control group prevented
us from drawing any deﬁnitive conclusions regarding the nature
of this sexual dimorphism (Mendrek, 2007). Thus, we collected
data in an independent sample of 42 patients (21 women) and 42
healthy controls during processing of emotionalmaterial, aswell as
FIGURE 3 |Voxel-based morphometry (VBM) analysis of parietal gray
matter densities.
during performance of a purely cognitive task of visuo-spatial pro-
cessing, which involved mental rotation of 3D-ﬁgures (known to
elicit robust sex differences in the general population). The behav-
ioral data alone revealed an interesting reversal of normal sexual
dimorphism, with superior performance of healthy males relative
to healthy females, and the reverse pattern in patients (Jiménez
et al., 2009, 2010). The fMRI results were consistent and showed
more extensive cerebral activations (in the parietal and lateral pre-
frontal cortex) in healthy men relative to healthy women, while in
patients it was women who exhibited more signiﬁcant activations
than men (Jiménez et al., 2009, 2010). Interestingly brain activa-
tions during the performance of mental rotation task by healthy
males and schizophrenia females (but not in schizophrenia males
and control females) were positively correlated with the plasma
levels of testosterone (Mendrek et al., 2011). The brain activa-
tion during processing of emotional stimuli and during emotional
memory also revealed disturbed sexual dimorphism in patients
relative to controls (in preparation for publication).Altogether, the
reversal of sexual dimorphism in brain processing in schizophre-
nia patients suggest that brain processing in male SZ patients may
be feminized, while brain processing in female SZ patients may be
masculinized. The mechanisms underlying this effect need to be
further examined (e.g., organizational versus activational effects
of sex steroid hormones, genetic versus environmental factors).
DEPRESSION
Major depressive disorder is characterized by affective, cogni-
tive, and somatic symptoms such as: depressed mood, diminished
interest and pleasure in most activities, signiﬁcant weight loss (or
weight gain), insomnia (or hypersomnia), fatigue, loss of energy,
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feelings of guilt, and worthlessness, diminished ability to concen-
trate, recurrent thoughts of death, and suicidal ideation.More than
half of suicides occur in the context of depressive disorder (Barr-
aclough et al., 1974; Hagnell and Rorsman, 1979). Twin and other
family studies indicate that genetic factors contribute substantially
(but less than in SZ or BP) to the liability for developing MDD,
particularly in cases characterized by recurrent illness and early
age-at-onset (30% in monozygotic twins; Sullivan et al., 2000).
Stressful events are thought to interact with genetic susceptibil-
ity in the development of mood disorders and may contribute
to the neurochemical imbalance. The disturbance in the sero-
tonin and norepinephrine activity has been strongly implicated,
as most antidepressant drugs exert their primary pharmacological
actions through these systems (Goodwin, 1993; Trivedi et al., 2006;
Ansorge et al., 2007;Dunlop andNemeroff, 2007;Gartlehner et al.,
2008; Kirsch et al., 2008).
Sex differences in clinical expression
The overall lifetime prevalence of MDD in women is approx-
imately twice that of men (Kessler, 2003; Smith et al., 2008);
ranging anywhere from 10 to 25% for women and 5 to 12%
for men (Barraclough et al., 1974). This difference however is
not apparent prior to puberty and in the years after menopause
(Weissman and Olfson, 1995). Moreover, women are two to four
times more likely than men to present with a seasonal compo-
nent (Leibenluft, 1999; Leibenluft et al., 1999), atypical features
(increased appetite, weight gain, hypersomnia), and higher lev-
els of somatic complains, ruminations, feelings of worthlessness,
and guilt (Hirschfeld et al., 1984). As the number of symptoms
increases, so does the female/male prevalence ratio (Kornstein
et al., 2000). Several explanations have been advanced to account
for the differences between men and women in the prevalence
and expression of MDD, including hormonal inﬂuences and
psychosocial factors.
Hormonal implications
Sex differences in the prevalence of MDD have been typically
attributed to the endocrine system, speciﬁcally the inﬂuence of
estrogen in women. This explanation has been put forth because:
(1) the rates of MDD are similar in girls and boys before puberty
and the sex difference is less prominent in elderly people (Sprock
and Yoder, 1997; Angst, 1998); (2) mood often appears to ﬂuctu-
ate with the change of hormones; times of low estrogen – such
as the premenstrual and postpartum periods – are associated with
increased risk formooddisorder (Fink et al., 1996).Approximately
13% of new mothers experience clinically signiﬁcant depression
during the ﬁrst few months postpartum (O’Hara and Swain, 1996)
with rates as high as 26% among adolescent mothers (Trout-
man and Cutrona, 1990) and 38% among low-income mothers
(Hobfoll et al., 1995).
Psychosocial factors
In addition to the sex steroid hormones several psychosocial fac-
tors have been identiﬁed as potential contributors to the differ-
ential prevalence and expression of MDD in men and women.
For example, the female sex role socialization has been associated
with low self-esteem, low perceived control, pessimistic attribu-
tional styles, and dependency, all of which are vulnerability factors
for developing depression (Grigoriadis and Robinson, 2007). In
comparison, the masculine sex role socialization, which puts a
high-value on assertiveness and independence, may play a pro-
tective role in men. However, the encouragement of stoicism and
suppression of emotions may also prevent men from properly
identifying their depressed mood and seeking treatment (Accortt
et al., 2008).
Neuroanatomical data
Sex differences in the brains of MDD patients remain almost com-
pletely unexamined. In a study by Hastings et al. (2004) a different
pattern of volumetric changes was observed in depressed men and
women. Thus, relative to sex-matched controls, the anterior cin-
gulate was smaller in depressed men compared with depressed
women (this effect was in the opposite direction to that found
in schizophrenia; result discussed above) – a difference consistent
with the sexual dimorphism present in the general population,
but even more pronounced. In addition, depressed women, but
not depressed men, had a reduced volume of the amygdala com-
pared with controls (another result in the opposite direction to
what has been observed in schizophrenia patients). In the general
population it is males who have larger amygdala and therefore the
effect of a further reduction of the amygdala in depressed women
points again to exaggerated sexual dimorphism in MDD patients.
Overall, these results suggest that the biology of mood disorders
in females may differ in some aspects from males, and may con-
tribute to the higher rate of depression in women (Hastings et al.,
2004).
Overall, the existing ﬁndings of sex differences in SZ (and to
some extent BD) appear to be in the opposite direction to what
has been reported in MDD. For example, we know that being a
woman predisposes to the development of MDD and is associ-
ated with a more severe course of the illness. In schizophrenia,
on the other hand, it is being a man that is related to the pres-
ence of more neuroanatomical and cognitive deﬁcits, and a poorer
treatment outcome. In addition, the evidence is emerging that the
neuroanatomical sex differences inMDDare in the opposite direc-
tion to those observed in SZ and BD, though the effect has never
been systematically investigated.
POSTTRAUMATIC STRESS DISORDER
Posttraumatic stress disorder is a psychiatric disorder that can
occur following exposure to life threatening events that elicit over-
whelming fear, helplessness, and horror. The disorder is charac-
terized by the presence of three symptom groups: reexperiencing,
avoidance, and hyperarousal. Reexperiencing symptoms are intru-
sions of the traumatic memory in the form of distressing images,
nightmares, or dissociative experiences. These recollections serve
tomake the trauma-exposed person feel“haunted”by thememory
of the event. This is not only because the memory is uncon-
trollable, but also because it generates physical and emotional
responses associated with fear and terror. These responses result
in avoidance behaviors, which include active attempts to avoid
reminders of the traumatic event (including people, places, or
activities associated with the trauma), and more passive attempts
to avoid through emotional numbing and constriction of affect.
Hyperarousal symptoms, such as insomnia, irritability, impaired
concentration, hypervigilance, and increased startle responses
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reﬂect more “physiologic” manifestations of trauma exposure.
Together, these symptoms impair social, occupational, or inter-
personal functioning, and persist for at least a month following
the trauma in order to meet criteria for PTSD according to DSM-
IV. The U. S. National Comorbidity Survey Replication (NCS-R)
estimates the lifetime prevalence of PTSD among adults to be 6.8%
(Kessler et al., 2005).
Sex differences in clinical expression
Although men report signiﬁcantly more exposure to potentially
traumatic events than do women (with the exception of childhood
trauma), epidemiological studies ﬁnd higher rates of PTSD among
women thanmen (Helzer et al., 1987;Davidson et al., 1991; Breslau
et al., 1998; Breslau andAnthony, 2007). In theU.S., lifetime preva-
lence rates of PTSD are estimated at 3.6% among men and 9.7%
among women (National Comorbidity Survey, 2005). Further-
more, women with PTSD report more reexperiencing symptoms
and more severe symptoms (Zlotnick et al., 2001; Tolin and Foa,
2006), and worse quality of life outcomes than do men with the
disorder (Holbrook et al., 2002). Numerous theories regarding
women apparently heightened vulnerability to the development
of PTSD have been proposed, including the intimate, interper-
sonal nature of potentially traumatic events that women are more
likely to experience (i.e., higher rates of severe intimate partner
violence and sexual assault across the lifespan), the profoundly
corrosive, and damaging meanings inherent in these kinds of vio-
lations, the possibility that women may be prone to heightened
levels of emotional reactivity which could confer additional risk
for PTSD, and the potential that sex differences in behavioral and
psychological sequelae to trauma inﬂuence diagnostic presenta-
tion (e.g., internalizing versus externalizing symptoms; Pratchett
et al., 2010).
Hormonal implications
Biologically informed research on PTSD has particularly focused
on the hypothalamic-pituitary-adrenal (HPA) axis, themajor con-
stituent of the neuroendocrine response to acute and chronic
stress (Yehuda, 2006). Although the ﬁndings have not always been
consistent, studies of the HPA axis and PTSD document a dis-
tinct neuroendocrine proﬁle in that catecholamine and CRF levels
appear to be increased in this disorder but urinary and plasma
levels of cortisol have been found to be lower than in normal (for
review, see Yehuda, 2002). Such ﬁndings have led to the devel-
opment of a model of PTSD in which increased glucocorticoid
receptor sensitivity leads to reduced levels of circulating cortisol,
contributing to a failure of the autoregulation system to con-
tain sympathetic activation and re-establish homeostasis following
removal of a threat.
Data on sex differences in PTSD-related biology are limited.
However, research on sex differences in the neuroendocrinology
of PTSD has documented some differences in cortisol and cat-
echolamines among subjects with PTSD. For example, among
children with PTSD, girls had signiﬁcantly elevated cortisol com-
pared to boys (Carrion et al., 2002), and a cortisol study of
adults with PTSD found that women’s salivary cortisol levels
decreased throughout the daywhereasmen’s levels increased (Frei-
denberg et al., 2010). Epinephrine and norepinephrine have been
associated with PTSD symptoms at 1 and 5months following
trauma exposure for men but not for women (Hawk et al., 2000).
CRF receptor functions have also been found to render women
more sensitive to low CRF and less adaptable to high levels, poten-
tially contributing to women’s disproportionate development of
PTSD (Bangasser et al., 2010).
Neuroanatomical data
Neuroanatomical differences in human males and females with
PTSD have also been identiﬁed. For example, while MRI studies
of children with maltreatment-related PTSD found overall differ-
ences in the brains of childrenwith PTSD versus controls, they also
found sex differences within the PTSD group. Males had greater
corpus callosum reduction (De Bellis et al., 1999), larger prefrontal
lobe cerebrospinal ﬂuid volumes and smaller splenium, smaller
cerebral volumes and corpus callosum regions 1 (rostrum) and
6 (isthmus), and greater lateral ventricular volume increases (De
Bellis andKehavan, 2003). FunctionalMRI research has also found
that enhanced brainstem activity is associated with a diagnosis of
PTSD for men but not for women, and that men with PTSD show
greater hippocampal activity in response to fear than their female
counterparts. However, observed differences may reﬂect norma-
tive sex differences on these parameters rather than sex differences
in pathophysiology or risk for PTSD. For example, adult males
havehigher basal cortisol levels thanwomen (e.g.,Vierhapper et al.,
1998; Takai et al., 2007).
Molecular biologic data
Recent data from emerging molecular biologic studies of PTSD
have also identiﬁed sex differences. For example, a recent study
of gene expression in PTSD found differential patterns of mono-
cyte gene expression in men and women (Neylan et al., 2011).
Whereas men with PTSD (n = 24) were found to have three
under-expressed genes, women PTSD subjects (n = 10) had both
increased and decreased gene expression. Furthermore, men
demonstrated no evidence of chronic inﬂammation, as hypothe-
sized, but women did demonstrate elevated inﬂammatory activity.
Separate analyses of these data (O’Donovan et al., 2011) also found
that men and women differed on regulation of target genes for
CREB/ATF,with men showing up-regulation and women showing
down-regulation. Males and females both showed up-regulation
of target genes for the NF-KB/Rel family of transcription factors
and down-regulation of target genes for the glucocorticoid recep-
tor. Sex differences have also been identiﬁed in the associations
of PTSD with pituitary adenylate cyclase-activating polypeptide
(PACAP), involved in cellular stress response, and the PAC1 recep-
tor pathway (Ressler et al., 2011). PACAP blood levels were asso-
ciated with PTSD symptoms and diagnosis, and with conditioned
fear response, forwomenonly. PACAP levels predicted response on
the three symptom clusters of PTSD for women but not for men.
A SNP in an estrogen response element in the PAC1 receptor pre-
dictedPTSD symptoms anddiagnosis forwomenonly, implicating
estrogen in the regulation of pathways relevant to sex differences
in rates of PTSD symptomatology and diagnosis.
DRUG ABUSE
The National Institute on Drug Abuse has described drug addic-
tion as a chronic, relapsing brain disease that is characterized
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by compulsive drug seeking and use, despite harmful conse-
quences2. Addiction is the progression from impulsive to com-
pulsive behavior of drug taking and it occurs in three stages: (1)
binge/intoxication; (2) withdrawal/negative affect; and (3) preoc-
cupation/anticipation (Viveros et al., 2011a). Substance abuse and
addiction are enormous public health concerns in many areas and
they are often linked to other psychiatric disorders (Lynch et al.,
2010). The results of animal models and clinical studies show that
there are sex differences at every phase of the drug reinforcement
process. For the majority of drugs of abuse, women are more
vulnerable (Becker and Hu, 2008) and exhibit higher rates of self-
administration (Fattore et al., 2007; Biscaia et al., 2008). Sexual
dimorphisms in drug abuse patterns are observed in humans in
the intake of psychoactive stimulants, alcohol, opioids, and mar-
ijuana (Becker and Hu, 2008; Gillies and McArthur, 2010). Such
differences have been attributed historically to sociocultural and
hormonal factors (Barker et al., 2010); however, an increasing body
of evidence indicates that these cultural inﬂuences are changing
and that the use, abuse, and dependence are increasing faster in
women.
Sex differences in epidemiological studies
Epidemiological studies show thatmenhavehigher rates of alcohol
dependence and abuse (Kalaydjian et al., 2009); however, animal
models show that females are more prone to consume alcohol
than males (Lancaster et al., 1996; Middaugh et al., 1999). This
lack of correlation between humans and animals models could be
due to sociocultural factors, but this trend in alcohol consump-
tion and abuse is changing as well as for other drugs as cocaine.
Studies with psychostimulants show that cocaine abuse has par-
ticularly increased among women, and mounting evidence shows
that women are more vulnerable to some aspects of psychostim-
ulants abuse. Epidemiological studies in the late 1980s (Grifﬁn
et al., 1989; Mendelson et al., 1991) indicated that women begin
using cocaine and amphetamines earlier than men, that they have
more severe cocaine use and that women progress to dependence
faster than do men (known as a “telescoped course”). Addition-
ally, addicted women present with a higher incidence of comorbid
psychiatric conditions, such as depression or PTSD (Najavits and
Lester, 2008) and also women show higher levels of craving and
longer periods of use after abstinence than men (Becker and Hu,
2008). There are also evidences proving that humans present sex
differences in biological and behavioral effects of cannabis use
(Fattore et al., 2008), but the mechanisms or origin of these differ-
ences are not well known yet. Men present higher circulating levels
of cannabis psychoactive compound, the tetrahydrocannabinol
(THC), are more sensitive to the subjective effects of THC (Haney,
2007), present more withdrawal symptoms (Crowley et al., 1998),
and are more likely to be polysubstance users and show a higher
prevalence in panic and personality disorders after abuse (Hasin
et al., 2008).
Hormonal implications
Some studies found that the effects of psychostimulants vary
across the menstrual cycle – they are potentiated during the late
2www.drugabuse.gov
luteal phase (when estradiol and progesterone levels are declin-
ing; Becker and Hu, 2008). Thus, the basis for the sex differ-
ence in response to cocaine is generally believed to be due to
estrogen (Dow-Edwards, 2010). Animal models of cocaine self-
administration reveal sex differences in the acquisition phase that
are independent of hormonal factors, with females being more
vulnerable than males. However, the motivation to take cocaine is
hormone dependent; estradiol enhances themotivation of cocaine
intake and it plays a key role in the reinforcing effects of psy-
chostimulants (Becker and Hu, 2008). Clinical studies show that
women aremore vulnerable thanmen to the transition from recre-
ational use to drug abuse (Randall et al., 1999), and that they are
more sensitive to the addictive properties of drugs (Lynch et al.,
2002). However, there is some evidence suggesting that women
experience weaker effects of THC. This could be due to sex differ-
ences in drug disposition and the distribution of fat tissue (this is
a hormone dependent factor) that helps sequester lipophilic com-
pounds like cannabinoids, as well as the possibility that women
may metabolize cannabinoid compounds faster than men. The
lack of correlation with some preclinical studies may be because
male rodents have a higher percentage of fat tissue than females.
As a result, more THC would be retained by fat cells (Fattore and
Fratta, 2010), which would diminish the amount of THC reaching
the brain and thereby affect the behavioral effects of cannabinoids
(Rubino and Parolaro, 2011). It is also important to notice that
there is an overlap between stress-system responses and the effects
of drugs because the majority of them are able to stimulate the
hypothalamic-pituitary-adrenal axis. In laboratory animals, some
stress models have been shown to increase the acquisition and
reinstatement of stimulants, opiates, and alcohol (Fox and Sinha,
2009). This same relationship has been observed in humans,where
chronic stress plays a very important role in the motivation to
abuse drugs and alcohol (Sinha, 2001). HPA axis responses are
also sex-dependent, thus providing another possible explanation
for why women are more vulnerable than men to the negative
effects of drugs (Fox and Sinha, 2009).
Neuroanatomical data
The reward system is a group of brain structures which regulate
and control behavior by inducing pleasurable effects. The major
rewarding pathway in the brain is the mesolimbic pathway and
goes from the ventral tegmental area (VTA) via the medial fore-
brain bundle to the NAc, which is the primary release site for
the neurotransmitter dopamine (Viveros et al., 2011a). Epidemi-
ological studies suggest that some differences in vulnerability to
drug abuse could be due to dimorphisms in reward pathways or
dopamine release as well as in reward-related structures like NAc,
PFC, or amygdale; this last has been shown to be inﬂuenced by
pubertal hormones in structural and organizational events (see
Gillies and McArthur, 2010 for review).
CONCLUDING REMARKS
In conclusion, what experimental and epidemiological studies tell
us is that sex differences in the brain appear to be predomi-
nantly established during developmentally sensitive time intervals
(i.e., in utero, perinatal, and adolescence periods). According to
the classical view of brain sexual differentiation, organizational
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effects are permanent structural changes arising from the actions
of in utero and perinatal sex hormones,whereas activational effects
are direct and temporary inﬂuences of circulating gonadal hor-
mones on function and behavior following puberty. However, we
now know that the SRY can begin directing sexual differentia-
tion prior to onset of hormonal secretions from the fetal testes.
In addition, sex chromosomal complement and transcription fac-
tors like Sox9 make important contributions to the process of
sexual differentiation. Moreover, it has been recently proposed
that steroid-dependent organization of behavior may also occur
during adolescence, which indicates the possibility of a reassess-
ment of the developmental time-frame for organizational effects
of gonadal steroids (Weinberg et al., 2008; Schulz et al., 2009).
Both preclinical and clinical studies show that the effects of stress-
ful events are sex and time-dependent. The susceptibility to disease
or dysfunction and the effect of injury/stress can be as much as
twofold to ﬁvefold greater in one sex; depending on the psychi-
atric disorder. These include higher rates of neuropsychiatric and
learning disorders with developmental origins in males and higher
rates of aging relatedneurodegenerative diseases andmental health
dysfunctions in females (McCarthy and Arnold, 2011). For a long
time, some of these differences has been explained by the inﬂuence
of genetic background, circulating levels of gonadal hormones, or
educational and psychosocial factors in humans, however epige-
netic and reprogramming processes are becoming more and more
important regarding the sexually dimorphisms of psychiatric dis-
orders. The combination of genomics, proteomics,metabolomics,
behavioral, neuroimaging, and neuroendocrinological techniques,
as well as the performance of studies with both sexes, could lead to
a better understanding of these disorders and to the development
of effective treatments depending on sex because, as both human
and animal studies suggest: sex matters.
ACKNOWLEDGMENTS
This work was supported by Instituto de Salud Carlos III, Redes
temáticas de InvestigaciónCooperativa en salud (ISCIII y FEDER):
Red de trastornos adictivos RD06/0001/1013; GRUPOS UCM-
BSCH – 951579; Ministerio de Ciencia e Innovación BFU2009-
10109, and Plan Nacional sobre Drogas at SAS/1250/2009 ofﬁcial
notiﬁcation.
REFERENCES
Accortt, E. E., Freeman, M. P., and
Allen, J. J. (2008). Women and
major depressive disorder: clinical
perspectives on causal pathways.
J. Womens Health (Larchmt.) 17,
1583–1590.
Adriani, W., and Laviola, G. (2000).
A unique hormonal and behavioral
hyporesponsivity to both forced
novelty and d-amphetamine in peri-
adolescent mice. Neuropharmacol-
ogy 39, 334–346.
Adriani, W., and Laviola, G. (2004).
Windows of vulnerability to psy-
chopathology and therapeutic strat-
egy in the adolescent rodent model.
Behav. Pharmacol. 15, 341–352.
Akhondzadeh, S., Rezaei, F., Lari-
jani, B., Nejatisafa, A. A., Kashani,
L., and Abbasi, S. H. (2006).
Correlation between testosterone,
gonadotropins and prolactin and
severity of negative symptoms in
male patients with chronic schizo-
phrenia. Schizophr. Res. 84, 405–410.
American Psychiatry Association
(APA). (1994). Diagnostic and
Statistical Manual of Mental Dis-
orders. Washington, DC: American
Psychiatric Press.
Andersen, M. L., Sawyer, E. K., and
Howell, L. L. (2012). Contributions
of neuroimaging to understanding
sex differences in cocaine abuse. Exp.
Clin. Psychopharmacol. 20, 2–15.
Andia, A. M., Zisook, S., Heaton, R.
K., Hesselink, J., Jernigan, T., Kuck,
J., Morganville, J., and Braff, D. L.
(1995). Gender differences in schiz-
ophrenia. J. Nerv. Ment. Dis. 183,
522–528.
Andreasen, N. C., and Carpenter, W.
T. Jr. (1993). Diagnosis and classi-
ﬁcation of schizophrenia. Schizophr.
Bull. 19, 199–214.
Andreasen, N. C., Ehrhardt, J. C.,
Swayze,V.W. II,Alliger, R. J.,Yuh,W.
T., Cohen, G., and Ziebell, S. (1990).
Magnetic resonance imaging of the
brain in schizophrenia. The patho-
physiologic signiﬁcance of structural
abnormalities. Arch. Gen. Psychiatry
47, 35–44.
Andreasen, N. C., Flashman, L., Flaum,
M., Arndt, S., Swayze, V. II, O’Leary,
D. S., Ehrhardt, J. C., and Yuh, W.
T. (1994). Regional brain abnormal-
ities in schizophrenia measured with
magnetic resonance imaging. JAMA
272, 1763–1769.
Angst, J. (1998). Treated versus
untreated major depressive
episodes. Psychopathology 31,
37–44.
Ansorge,M. S., Hen, R., and Gingrich, J.
A. (2007). Neurodevelopmental ori-
gins of depressive disorders. Curr.
Opin. Pharmacol. 7, 8–17.
Arango, N. A., Lovell-Badge, R., and
Behringer, R. R. (1999). Targeted
mutagenesis of the endogenous
mouse Mis gene promoter: in vivo
deﬁnitionof genetic pathways of ver-
tebrate sexual development. Cell 4,
409–419.
Arnold,A. P., andChen,X. (2009).What
does the four core genotypes mouse
model tell us about sex differences
in the brain and other tissues? Front.
Neuroendocrinol. 30, 1–9.
Bagheri-Fam, S., Barrionuevo, F.,
Dohrmann, U., Gunther, T., Schule,
R., Kemler, R., Mallo, M., Kanzler,
B., and Scherer, G. (2006). Long-
range upstream and downstream
enhancers control distinct subsets
of the complex spatiotemporal Sox9
expression pattern. Dev. Biol. 291,
382–397.
Balster, R. L. (1991). Drug abuse poten-
tial evaluation in animals. Br. J.
Addict. 86, 1549–1558.
Bangasser, D. A., Curtis, A., Reyes, B. A.,
Bethea, T. T., Parastatidis, I., Ischi-
ropoulos, H., Van Bockstaele, E. J.,
and Valentino, R. J. (2010). Sex dif-
ferences in corticotropin-releasing
factor receptor signaling and traf-
ﬁcking: potential role in female
vulnerability to stress-related psy-
chopathology. Mol. Psychiatry 15,
896–904.
Barbeau, E. B., Mendrek, A., and Mot-
tron, L. (2009). Are autistic traits
autistic? Br. J. Psychol. 100, 23–28.
Barker, J. M., Torregrossa, M. M.,
Arnold,A. P., andTaylor, J. R. (2010).
Dissociation of genetic and hor-
monal inﬂuences on sex differences
in alcoholism-related behaviors. J.
Neurosci. 30, 9140–9144.
Baron-Cohen, S. (2002). The extreme
male brain theory of autism. Trends
Cogn. Sci. (Regul. Ed.) 6, 248–254.
Baron-Cohen, S. (2009). Autism: the
empathizing-systemizing (E-S) the-
ory. Ann. N. Y. Acad. Sci. 1156,
68–80.
Barraclough, B., Bunch, J., Nelson, B.,
and Sainsbury, P. (1974). A hundred
cases of suicide: clinical aspects. Br.
J. Psychiatry 125, 355–373.
Becker, J. B., and Hu,M. (2008). Sex dif-
ferences in drug abuse. Front. Neu-
roendocrinol. 29, 36–47.
Beery, A. K., and Zucker, I. (2011). Sex
bias in neuroscience and biomedical
research. Neurosci. Biobehav. Rev. 35,
565–572.
Bergemann, N., Parzer, P., Run-
nebaum, B., Resch, F., and Mundt,
C. (2007). Estrogen, menstrual
cycle phases, and psychopathol-
ogy in women suffering from
schizophrenia. Psychol. Med. 37,
1427–1436.
Bernard, P., Ryan, J., Sim, H., Czech,
D. P., Sinclair, A. H., Koopman,
P., and Harley, V. R. (2012). Wnt
signaling in ovarian development
inhibits Sf1 activation of Sox9 via the
Tesco enhancer. Endocrinology 153,
901–912.
Bernard, P., Tang, P., Liu, S., Dewing, P.,
Harley, V. R., and Vilain, E. (2003).
Dimerization of SOX9 is required
for chondrogenesis, but not for sex
determination. Hum. Mol. Genet. 12,
1755–1765.
Bhandari, R. K., Sadler-Riggleman, I.,
Clement, T. M., and Skinner, M.
K. (2011). Basic helix-loop-helix
transcription factor TCF21 is a
downstream target of the male
sex determining gene SRY. PLoS
ONE 6, e19935. doi:10.1371/jour-
nal.pone.0019935
Biscaia, M., Fernandez, B., Higuera-
Matas, A., Miguens, M., Viveros,
M. P., Garcia-Lecumberri, C., and
Ambrosio, E. (2008). Sex-dependent
effects of periadolescent exposure to
the cannabinoid agonist CP-55,940
on morphine self-administration
behaviour and the endogenous opi-
oid system. Neuropharmacology 54,
863–873.
www.frontiersin.org June 2012 | Volume 6 | Article 84 | 15
Viveros et al. Neurobehavioral sexual dimorphisms
Biscaia, M., Marin, S., Fernandez,
B., Marco, E. M., Rubio, M.,
Guaza, C., Ambrosio, E., and
Viveros, M. P. (2003). Chronic treat-
ment with CP 55,940 during the
peri-adolescent period differentially
affects the behavioural responses
of male and female rats in adult-
hood. Psychopharmacology (Berl.)
170, 301–308.
Blazer, D. G., Kessler, R. C., McGonagle,
K. A., and Swartz, M. S. (1994). The
prevalence anddistribution of major
depression in a national commu-
nity sample: the National Comor-
bidity Survey. Am. J. Psychiatry 151,
979–986.
Bourke, C. H., and Neigh, G. N. (2011).
Behavioral effects of chronic ado-
lescent stress are sustained and sex-
ually dimorphic. Horm. Behav. 60,
112–120.
Breslau, N., and Anthony, J. C. (2007).
Gender differences in the sensitiv-
ity to posttraumatic stress disorder:
an epidemiological study of urban
young adults. J. Abnorm. Psychol.
116, 607–611.
Breslau, N., Kessler, R. C., Chilcoat, H.
D., Schultz, L. R., Davis, G., and
Andreski, P. (1998). Trauma and
posttraumatic stress disorder: the
1996 Detroit area survey of trauma.
Arch. Gen. Psychiatry 55, 626–632.
Campbell, U. C., and Carroll, M. E.
(2000). Acquisition of drug self-
administration: environmental and
pharmacological interventions. Exp.
Clin. Psychopharmacol. 8, 312–325.
Canastar, A., Maxson, S. C., and Bishop,
C. E. (2008). Aggressive and mat-
ing behaviors in two types of sex
reversed mice: XY females and XX
males. Arch. Sex. Behav. 37, 2–8.
Carrion, V., Weems, C., Ray, R., Glaser,
B., Hessl, B., and Reiss, A. (2002).
Diurnal salivary cortisol in pediatric
posttraumatic stress disorder. Biol.
Psychiatry 51, 575–582.
Chang, S. S., and Renshaw,D. C. (1986).
Psychosis and pregnancy. Compr.
Ther. 12, 36–41.
Cheung, M., Abu-Elmagd, M., Clevers,
H., and Scotting, P. J. (2000). Roles
of Sox4 in central nervous system
development. Brain Res. Mol. Brain
Res. 79, 180–191.
Cohen, R. Z., Seeman, M. V., Gotowiec,
A., and Kopala, L. (1999). Earlier
puberty as a predictor of later onset
of schizophrenia in women. Am. J.
Psychiatry 156, 1059–1064.
Craft, R. M., Mogil, J. S., and Aloisi, A.
M. (2004). Sex differences in pain
and analgesia: the role of gonadal
hormones. Eur. J. Pain 8, 397–411.
Crespi, B., and Badcock, C. (2008). Psy-
chosis and autism as diametrical
disorders of the social brain. Behav.
Brain Sci. 31, 241–261.
Crowley, T. J., MacDonald, M. J.,
Whitmore, E. A., and Mikulich, S.
K. (1998). Cannabis dependence,
withdrawal, and reinforcing effects
among adolescents with conduct
symptoms and substance use dis-
orders. Drug Alcohol Depend. 50,
27–37.
Davidson, J. R., Hughes, D., Blazer, D.
G., and George, L. K. (1991). Post-
traumatic stress disorder in the com-
munity: an epidemiological study.
Psychol. Med. 21, 713–721.
De Bellis, M., and Kehavan, M. (2003).
Sex differences in brain matura-
tion in maltreatment-related pedi-
atric posttraumatic stress disorder.
Neurosci. Biobehav. Rev. 27, 103–117.
De Bellis, M., Keshavan, M., Clark,
C., Casey, B., Giedd, J., Boring, A.,
Frustaci, K., and Ryan, N. (1999).
A.E. Bennett ResearchAward.Devel-
opmental traumatology. Part II:
Brain development. Biol. Psychiatry
45, 1271–1284.
De Santa, B. P., Bonneaud, N., Boizet,
B., Desclozeaux, M., Moniot, B.,
Sudbeck, P., Scherer, G., Poulat, F.,
and Berta, P. (1998). Direct inter-
action of SRY-related protein SOX9
and steroidogenic factor 1 regulates
transcription of the human anti-
Mullerian hormone gene. Mol. Cell.
Biol. 18, 6653–6665.
de Vries, G. J., Duetz, W., Buijs, R. M.,
van Heerikhuize, J., and Vreeburg,
J. T. (1986). Effects of androgens
and estrogens on the vasopressin and
oxytocin innervation of the adult rat
brain. Brain Res. 399, 296–302.
Deiana, S., Fattore, L., Spano, M. S.,
Cossu, G., Porcu, E., Fadda, P.,
and Fratta, W. (2007). Strain and
schedule-dependent differences in
the acquisition, maintenance and
extinction of intravenous cannabi-
noid self-administration in rats.
Neuropharmacology 52, 646–654.
Dewing, P., Shi, T., Horvath, S., and
Vilain,E. (2003). Sexually dimorphic
gene expression in mouse brain pre-
cedes gonadal differentiation. Brain
Res. Mol. Brain Res. 118, 82–90.
Dluzen, D. E., and McDermott, J.
L. (2006). Estrogen, testosterone,
and methamphetamine toxic-
ity. Ann. N. Y. Acad. Sci. 1074,
282–294.
Doremus-Fitzwater, T. L., Varlinskaya,
E. I., and Spear, L. P. (2009).
Social and non-social anxiety in
adolescent and adult rats after
repeated restraint.Physiol. Behav. 97,
484–494.
Dow-Edwards, D. (2010). Sex differ-
ences in the effects of cocaine abuse
across the life span. Physiol. Behav.
100, 208–215.
Dow-Edwards, D., Dasari, V. M.,
Menendez, R., Lugo-Escobar, N.,
Torres-Reveron, A., and Segarra, A.
C. (2005). Alterations in brain glu-
cose metabolism following repeated
cocaine in adult rats: sex and gonadal
status. Abstr. Soc. Neurosci.
Draganski, B., Gaser, C., Busch, V.,
Schuierer, G., Bogdahn,U., and May,
A. (2004). Neuroplasticity: changes
in grey matter induced by training.
Nature 427, 311–312.
Driemeyer, J., Boyke, J., Gaser, C.,
Buchel, C., and May, A. (2008).
Changes in gray matter induced
by learning – revisited. PLoS
ONE 3, e2669. doi:10.1371/jour-
nal.pone.0002669
Dunlop, B. W., and Nemeroff, C. B.
(2007). The role of dopamine in
the pathophysiology of depression.
Arch. Gen. Psychiatry 64, 327–337.
Dunn, G. A., Morgan, C. P., and
Bale, T. L. (2011). Sex-speciﬁcity
in transgenerational epigenetic
programming. Horm. Behav. 59,
290–295.
Ellenbroek, B. A., de Bruin, N. M., van
Den Kroonenburg, P. T., van Luijte-
laar, E. L., and Cools, A. R. (2004).
The effects of early maternal depri-
vation on auditory information pro-
cessing in adult Wistar rats. Biol.
Psychiatry 55, 701–707.
Ellenbroek, B. A., and Riva, M. A.
(2003). Early maternal deprivation
as an animal model for schizophre-
nia. Clin. Neurosci. 3, 297–302.
Evans, A. C., and Brain Development
Cooperative Group. (2006). The
NIH MRI study of normal brain
development. Neuroimage 1, 184–
202.
Fatemi, S. H., and Folsom, T. D. (2009).
The neurodevelopmental hypothesis
of schizophrenia, revisited. Schizo-
phr. Bull. 35, 528–548.
Fattore, L., Altea, S., and Fratta, W.
(2008). Sex differences in drug
addiction: a review of animal and
human studies. Womens Health
(Lond. Engl.) 4, 51–65.
Fattore, L., and Fratta, W. (2010). How
important are sex differences in
cannabinoid action? Br. J. Pharma-
col. 160, 544–548.
Fattore, L., Spano, M. S., Altea,
S., Angius, F., Fadda, P., and
Fratta, W. (2007). Cannabinoid self-
administration in rats: sex differ-
ences and the inﬂuence of ovar-
ian function. Br. J. Pharmacol. 152,
795–804.
Fernández-Espejo, E., Viveros, M. P.,
Nunez, L., Ellenbroek, B. A., and
Rodriguez de, F. F. (2009). Role
of Cannabis and endocannabi-
noids in the genesis of schizophre-
nia. Psychopharmacology (Berl.) 206,
531–549.
Fink, G., Sumner, B. E., Rosie, R., Grace,
O., and Quinn, J. P. (1996). Estrogen
control of central neurotransmis-
sion: effect on mood, mental state,
and memory. Cell. Mol. Neurobiol.
16, 325–344.
Flaum, M., O’Leary, D. S., Swayze, V.
W. II, Miller, D. D., Arndt, S., and
Andreasen, N. C. (1995). Symptom
dimensions and brain morphology
in schizophrenia and related psy-
chotic disorders. J. Psychiatr. Res. 29,
261–276.
Flor-Henry, P. (1985). Schizophrenia:
sex differences. Can. J. Psychiatry 30,
319–322.
Fox, H. C., and Sinha, R. (2009).
Sex differences in drug-related
stress-system changes: implications
for treatment in substance-abusing
women. Harv. Rev. Psychiatry 17,
103–119.
Frazier, J. A., Hodge, S. M., Breeze, J. L.,
Giuliano, A. J., Terry, J. E., Moore, C.
M., Kennedy, D. N., Lopez-Larson,
M. P., Caviness, V. S., Seidman, L. J.,
Zablotsky, B., and Makris,N. (2008).
Diagnostic and sex effects on limbic
volumes in early-onset bipolar dis-
order and schizophrenia. Schizophr.
Bull. 34, 37–46.
Freidenberg, B., Gusmano, R., Hickling,
E., Blanchard, E., Bremner, E., and
Frye, C. (2010). Women with PTSD
have lower basal salivary levels later
in the day than do men with PTSD:
a preliminary study. Physiol. Behav.
99, 234–236.
Gartlehner, G., Thieda, P., Hansen,
R. A., Gaynes, B. N., Deveaugh-
Geiss, A., Krebs, E. E., and Lohr,
K. N. (2008). Comparative risk for
harms of second-generation anti-
depressants: a systematic review
and meta-analysis. Drug Saf. 31,
851–865.
Gatewood, J. D., Wills, A., Shetty, S.,
Xu, J., Arnold, A. P., Burgoyne, P. S.,
and Rissman, E. F. (2006). Sex chro-
mosome complement and gonadal
sex inﬂuence aggressive and parental
behaviors in mice. J. Neurosci. 26,
2335–2342.
Gattaz, W. F., Vogel, P., Riecher-Rossler,
A., and Soddu, G. (1994). Inﬂuence
of the menstrual cycle phase on the
therapeutic response in schizophre-
nia. Biol. Psychiatry 36, 137–139.
Gillies, G. E., and McArthur, S. (2010).
Estrogen actions in the brain and
the basis for differential action in
men and women: a case for sex-
speciﬁc medicines. Pharmacol. Rev.
62, 155–198.
Frontiers in Neuroscience | Neurogenomics June 2012 | Volume 6 | Article 84 | 16
Viveros et al. Neurobehavioral sexual dimorphisms
Gilmore, J. H., Lin,W., Prastawa, M. W.,
Looney, C. B., Vetsa, Y. S., Knick-
meyer, R. C., Evans, D. D., Smith,
J. K., Hamer, R. M., Lieberman, J.
A., and Gerig, G. (2007). Regional
gray matter growth, sexual dimor-
phism, and cerebral asymmetry in
the neonatal brain. J. Neurosci. 27,
1255–1260.
Goldstein, J. M., Seidman, L. J., Hor-
ton,N. J.,Makris,N.,Kennedy,D.N.,
Caviness, V. S. Jr., Faraone, S. V., and
Tsuang, M. T. (2001). Normal sex-
ual dimorphism of the adult human
brain assessed by in vivo magnetic
resonance imaging.Cereb. Cortex 11,
490–497.
Goldstein, J. M., Seidman, L. J., O’Brien,
L. M., Horton, N. J., Kennedy, D.
N., Makris, N., Caviness, V. S. Jr.,
Faraone, S. V., and Tsuang, M. T.
(2002). Impact of normal sexual
dimorphisms on sex differences in
structural brain abnormalities in
schizophrenia assessed by magnetic
resonance imaging. Arch. Gen. Psy-
chiatry 59, 154–164.
Goodwin, F. K. (1993). Predictors of
antidepressant response. Bull. Men-
ninger Clin. 57, 146–160.
Green, M. F. (2006). Cognitive impair-
ment and functional outcome in
schizophrenia and bipolar disorder.
J. Clin. Psychiatry 67, e12.
Grifﬁn, M. L.,Weiss, R. D., Mirin, S. M.,
and Lange, U. (1989). A comparison
of male and female cocaine abusers.
Arch. Gen. Psychiatry 46, 122–126.
Grigoriadis, S., and Robinson, G. E.
(2007). Gender issues in depression.
Ann. Clin. Psychiatry 19, 247–255.
Grigoriadis, S., and Seeman, M. V.
(2002). The role of estrogen in schiz-
ophrenia: implications for schiz-
ophrenia practice guidelines for
women. Can. J. Psychiatry 47,
437–442.
Gur,R.C.,Gunning-Dixon,F.M.,Turet-
sky, B. I., Bilker,W. B., and Gur, R. E.
(2002). Brain region and sex differ-
ences in age association with brain
volume: a quantitative MRI study of
healthy young adults. Am. J. Geriatr.
Psychiatry 10, 72–80.
Gur, R. E., Cowell, P. E., Latshaw, A.,
Turetsky, B. I., Grossman, R. I.,
Arnold, S. E., Bilker, W. B., and Gur,
R. C. (2000). Reduced dorsal and
orbital prefrontal gray matter vol-
umes in schizophrenia. Arch. Gen.
Psychiatry 57, 761–768.
Gur, R. E., Kohler, C., Turetsky, B. I.,
Siegel, S. J., Kanes, S. J., Bilker, W.
B., Brennan, A. R., and Gur, R. C.
(2004). A sexually dimorphic ratio
of orbitofrontal to amygdala vol-
ume is altered in schizophrenia. Biol.
Psychiatry 55, 512–517.
Hafner, H., an der Heiden, W., Behrens,
S., Gattaz, W. F., Hambrecht, M.,
Lofﬂer, W., Maurer, K., Munk-
Jorgensen, P., Nowotny, B., Riecher-
Rossler, A., and Stein, A. (1998).
Causes and consequences of the gen-
der difference in age at onset of
schizophrenia. Schizophr. Bull. 24,
99–113.
Hafner, H., Hambrecht, M., Lofﬂer, W.,
Munk-Jorgensen, P., and Riecher-
Rossler, A. (1998a). Is schizophrenia
a disorder of all ages? A compari-
son of ﬁrst episodes and early course
across the life-cycle. Psychol. Med.
28, 351–365.
Hagnell, O., and Rorsman, B. (1979).
Suicide in the Lundby study: a
comparative investigation of clin-
ical aspects. Neuropsychobiology 5,
61–73.
Hallonquist, J. D., Seeman, M. V.,
Lang, M., and Rector, N. A.
(1993). Variation in symptom sever-
ity over the menstrual cycle of
schizophrenics. Biol. Psychiatry 33,
207–209.
Han, T. M., and de Vries, G. J.
(2003). Organizational effects of
testosterone, estradiol, and dihy-
drotestosterone on vasopressin
mRNA expression in the bed
nucleus of the stria terminalis. J.
Neurobiol. 54, 502–510.
Han, X., Wu, X., Chung, W. Y., Li, T.,
Nekrutenko,A.,Altman,N. S., Chen,
G., and Ma, H. (2009). Transcrip-
tome of embryonic and neonatal
mouse cortex by high-throughput
RNA sequencing. Proc. Natl. Acad.
Sci. U.S.A. 106, 12741–12746.
Haney, M. (2007). Opioid antagonism
of cannabinoid effects: differences
between marijuana smokers and
nonmarijuana smokers. Neuropsy-
chopharmacology 32, 1391–1403.
Hankin, B. L., Mermelstein, R., and
Roesch, L. (2007). Sex differences in
adolescent depression: stress expo-
sure and reactivity models. Child
Dev. 78, 279–295.
Hasin, D. S., Keyes, K. M., Alderson,
D., Wang, S., Aharonovich, E., and
Grant, B. F. (2008). Cannabis with-
drawal in the United States: results
fromNESARC. J. Clin. Psychiatry 69,
1354–1363.
Hastings, R. S., Parsey, R. V., Oquendo,
M. A., Arango, V., and Mann, J.
J. (2004). Volumetric analysis of
the prefrontal cortex, amygdala,
and hippocampus in major depres-
sion. Neuropsychopharmacology 29,
952–959.
Hawk, L., Dougall, A., Ursano, R.,
and Baum, A. (2000). Urinary cat-
echolamines and recent onset post-
traumatic stress disorder aftermotor
vehicle accidents. Psychosom. Med.
62, 423–434.
Helzer, J. E., Robins, L. N., and McEvoy,
L. (1987). Post-traumatic stress dis-
order in the general population:
ﬁndings of the epidemiologic catch-
ment area survey. N. Engl. J. Med.
317, 1630–1634.
Hendrick, V., Altshuler, L. L., and Burt,
V. K. (1996). Course of psychiatric
disorders across the menstrual cycle.
Harv. Rev. Psychiatry 4, 200–207.
Herve, P. Y., Cox, E. F., Lotﬁpour, A.
K., Mougin, O. E., Bowtell, R. W.,
Gowland, P. A., and Paus, T. (2011).
Structural properties of the corti-
cospinal tract in the human brain:
a magnetic resonance imaging study
at 7 Tesla. Brain Struct. Funct. 216,
255–262.
Herve, P. Y., Leonard, G., Perron, M.,
Pike, G. B., Pitiot, A., Richer, L.,
Veillette, S., Pausova, Z., and Paus,
T. (2009). Handedness, motor skills
and maturation of the corticospinal
tract in the adolescent brain. Hum.
Brain Mapp. 30, 3151–3162.
Higuera-Matas, A., Soto-Montenegro,
M. L., del, O. N., Miguens, M.,
Torres, I., Vaquero, J. J., Sanchez,
J., Garcia-Lecumberri, C., Desco,
M., and Ambrosio, E. (2008). Aug-
mented acquisition of cocaine self-
administration and altered brain
glucose metabolism in adult female
but not male rats exposed to a
cannabinoid agonist during adoles-
cence.Neuropsychopharmacology 33,
806–813.
Hirschfeld, R. M., Klerman, G. L.,
Clayton, P. J., Keller, M. B., and
Andreasen, N. C. (1984). Person-
ality and gender-related differences
in depression. J. Affect. Disord. 7,
211–221.
Hobfoll, S. E., Ritter, C., Lavin, J., Hul-
sizer, M. R., and Cameron, R. P.
(1995). Depression prevalence and
incidence among inner-city preg-
nant and postpartum women. J.
Consult. Clin. Psychol. 63, 445–453.
Holbrook,T. L.,Hoyt,D. B., Stein,M. B.,
and Sieber, W. J. (2002). Gender dif-
ferences in long-term posttraumatic
stress disorder outcomes after major
trauma: women are at higher risk
of adverse outcomes than men. J.
Trauma. 53, 882–888.
Holtzman, S. G. (1990). “Discrimina-
tive stimulus effects of drugs: rela-
tionship to potential for abuse,” in
Testing and Evaluation of Drugs of
Abuse. Modern Methods in Pharma-
cology, Vol. 6, eds M. W. Adler and
A. Cowan (New York: Wiley-Liss),
197–210.
Irle, E., Lange, C., Ruhleder, M., Exner,
C., Siemerkus, J., and Weniger, G.
(2011). Hippocampal size in women
but not men with schizophrenia
relates to disorder duration. Psychi-
atry Res. 3,133–139.
Iwasaki-Sekin, A., ManoOtagiri, A.,
Ohata, H., Yamauchi, N., and
Shibasaki, T. (2009). Gender dif-
ferences in corticotrophin and
corticosterone secretion and
corticotrophin-releasing factor
mRNA expression in the paraven-
tricular nucleus of thehypothalamus
and the central nucleus of the amyg-
dale in response to footshock stress
or psychological stress in rats.
Psychoendocrinology 34, 226–237.
Jablenksy, A. (1992). Schizophrenia:
manifestations, incidence and
course in different cultures. A World
Health Organization ten-country
study. Psychol. Med. Monogr. Suppl.
20, 1–97.
Jankowski, M. P., Cornuet, P. K., McIl-
wrath, S., Koerber, H. R., and Albers,
K. M. (2006). SRY-box containing
gene 11 (Sox11) transcription factor
is required for neuron survival and
neurite growth. Neuroscience 143,
501–514.
Jiménez, J., Mancini-Marïe, A., Corco-
ran, C., Fahim, C., Karama, S., Beau-
regard, M., Lévesque, J., Mensour,
M., Stip, E., and Mendrek,A. (2008).
Laterality in grey matter densities of
the frontal lobe in men and women
with schizophrenia: a voxel-based
morphometry study. Schizophr. Res.
98, 38–39.
Jiménez, J., Mancini-Marie, A., and
Mendrek,A. (2009). The case for not
combining men and women in neu-
rocognitive studies for schizophre-
nia. Schizophr. Res. 108, 293–294.
Jiménez, J. A., Mancini-Marïe, A., Lakis,
N., Rinaldi, M., and Mendrek, A.
(2010). Disturbed sexual dimor-
phism of brain activation during
mental rotation in schizophrenia.
Schizophr. Res. 122, 53–62.
Kalaydjian,A., Swendsen, J., Chiu,W. T.,
Dierker, L., Degenhardt, L., Glantz,
M., Merikangas, K. R., Sampson,
N., and Kessler, R. (2009). Sociode-
mographic predictors of transitions
across stages of alcohol use, disor-
ders, and remission in the National
Comorbidity Survey Replication.
Compr. Psychiatry 50, 299–306.
Kandel, D. B., Yamaguchi, K., and Klein,
L. C. (2006). Testing the gateway
hypothesis. Addiction 101, 470–472.
Katz, J. L., and Higgins, S. T. (2003).
The validity of the reinstatement
model of craving and relapse to drug
use. Psychopharmacology (Berl.) 168,
21–30.
Kay, S. R., Fiszbein, A., Lindenmayer, J.
P., and Opler, L. A. (1986). Positive
www.frontiersin.org June 2012 | Volume 6 | Article 84 | 17
Viveros et al. Neurobehavioral sexual dimorphisms
and negative syndromes in schizo-
phrenia as a function of chronicity.
Acta Psychiatr. Scand. 74, 507–518.
Kendell, R. E., Chalmers, J. C., and Platz,
C. (1987). Epidemiology of puer-
peral psychoses.Br. J. Psychiatry 150,
662–673.
Kendler, K. S., and Diehl, S. R.
(1993). The genetics of schizophre-
nia: a current,genetic-epidemiologic
perspective. Schizophr. Bull. 19,
261–285.
Keshavan, M. S., Nasrallah, H. A., and
Tandon, R. (2011). Schizophrenia,
“just the facts” 6. Moving ahead with
the schizophrenia concept: from the
elephant to the mouse. Schizophr.
Res. 127, 3–13.
Keshavan, M. S., Tandon, R., Boutros,
N. N., and Nasrallah, H. A. (2008).
Schizophrenia, just the facts: what
we know in 2008 Part 3: neurobiol-
ogy. Schizophr. Res. 106, 89–107.
Kessler, R. C. (2003). Epidemiology of
women and depression. J. Affect.
Disord. 74, 5–13.
Kessler, R. C., Amminger, G. P., Guilar-
Gaxiola, S., Alonso, J., Lee, S., and
Ustun, T. B. (2007). Age of onset of
mental disorders: a review of recent
literature. Curr. Opin. Psychiatry 20,
359–364.
Kessler, R. C., Berglund, P., Delmer,
O., Jin, R., Merikangas, K. R.,
and Walters, E. E. (2005). Lifetime
prevalence and age-of-onset distri-
butions of DSM-IV disorders in
the National Comorbidity Survey
Replication. Arch. Gen. Psychiatry 6,
593–602.
Kim, D. K., Han, S. B., Hong, S. T.,
Choi, Y. J., Sun, W., Geum, D.,
and Kim, H. (2008). Expression of
Sox11 and Brn transcription fac-
tors during development and fol-
lowing transient forebrain ischemia
in the rat. Neurosci. Lett. 433,
259–264.
Kirsch, I., Deacon, B. J., Huedo-Medina,
T. B., Scoboria, A., Moore, T. J., and
Johnson, B. T. (2008). Initial sever-
ity and antidepressant beneﬁts: a
meta-analysis of data submitted to
the Food and Drug Administration.
PLoS Med. 5, e45. doi:10.1371/jour-
nal.pmed.0050045
Kline,N. S., Blair, J., Cooper, T. B., Esser,
A. H., Hackett, E., and Vestergaard,
P. (1968). A controlled seven year
study of endocrine and other indices
in drug treated chronic schizophren-
ics. Acta Psychiatr. Scand. Suppl. 206,
7–75.
Ko, Y. H., Jung, S. W., Joe, S. H., Lee,
C. H., Jung, H. G., Jung, I. K., Kim,
S. H., and Lee, M. S. (2007). Asso-
ciation between serum testosterone
levels and the severity of negative
symptoms in male patients with
chronic schizophrenia. Psychoneu-
roendocrinology 32, 385–391.
Kobayashi, A., Stewart, C. A., Wang, Y.,
Fujioka, K., Thomas, N. C., Jamin,
S. P., and Behringer, R. R. (2011).
beta-Catenin is essential for Mul-
lerian duct regression during male
sexual differentiation. Development
138, 1967–1975.
Konkle, A. T., and McCarthy, M. M.
(2011). Developmental time course
of estradiol, testosterone, and dihy-
drotestosterone levels in discrete
regions of male and female rat brain.
Endocrinology 152, 223–235.
Kornstein,S.G.,Schatzberg,A. F.,Thase,
M. E., Yonkers, K. A., McCullough,
J. P., Keitner, G. I., Gelenberg, A. J.,
Ryan,C. E.,Hess,A. L.,Harrison,W.,
Davis, S.M., andKeller,M.B. (2000).
Gender differences in chronic major
and double depression. J. Affect. Dis-
ord. 60, 1–11.
Kuo, J., Hamid, N., Bondar, G., Dewing,
P., Clarkson, J., and Micevych, P. E.
(2010). Sex differences in hypothal-
amic astrocyte response to estradiol
stimulation. Biol. Sex Differ. 1, 7.
Lancaster, F. E., Brown, T. D., Coker,
K. L., Elliott, J. A., and Wren, S.
B. (1996). Sex differences in alco-
hol preference and drinking patterns
emerge during the early postpuber-
tal period. Alcohol. Clin. Exp. Res. 20,
1043–1049.
Lauriello, J., Hoff, A., Wieneke, M.
H., Blankfeld, H., Faustman, W. O.,
Rosenbloom, M., DeMent, S., Sulli-
van, E. V., Lim, K. O., and Pfeffer-
baum, A. (1997). Similar extent of
brain dysmorphology in severely ill
women and men with schizophre-
nia. Am. J. Psychiatry 154, 819–825.
Laviola, G., Adriani, W., Morley-
Fletcher, S., and Terranova, M. L.
(2002). Peculiar response of adoles-
cent mice to acute and chronic stress
and to amphetamine: evidence of sex
differences. Behav. Brain Res. 130,
117–125.
Leibenluft, E. (1999). Gender differ-
ences in major depressive disorder
and bipolar disorder. CNS Spectr. 4,
25–33.
Leibenluft, E., Ashman, S. B., Feldman-
Naim, S., and Yonkers, K. A. (1999).
Lack of relationship between men-
strual cycle phase and mood in a
sample of women with rapid cycling
bipolar disorder. Biol. Psychiatry 46,
577–580.
Leranth, C., Petnehazy, O., and
MacLusky, N. J. (2003). Gonadal
hormones affect spine synaptic
density in the CA1 hippocampal
subﬁeld of male rats. J. Neurosci. 23,
1588–1592.
Leung, A., and Chue, P. (2000). Sex dif-
ferences in schizophrenia, a reviewof
the literature. Acta Psychiatr. Scand.
Suppl. 401, 3–38.
Ling, K. H., Hewitt, C. A., Beissbarth,
T., Hyde, L., Banerjee, K., Cheah,
P. S., Cannon, P. Z., Hahn, C.
N., Thomas, P. Q., Smyth, G. K.,
Tan, S. S., Thomas, T., and Scott,
H. S. (2009). Molecular networks
involved in mouse cerebral cortico-
genesis and spatio-temporal regula-
tion of Sox4 and Sox11 novel anti-
sense transcripts revealed by tran-
scriptome proﬁling. Genome Biol.
10, R104.
Llorente, R., Arranz, L., Marco, E. M.,
Moreno, E., Puerto, M., Guaza, C.,
De la, F. M., and Viveros, M. P.
(2007). Early maternal deprivation
and neonatal single administration
with a cannabinoid agonist induce
long-termsex-dependent psychoim-
munoendocrine effects in adolescent
rats. Psychoneuroendocrinology 32,
636–650.
Llorente, R., Miguel-Blanco, C., Aisa,
B., Lachize, S., Borcel, E., Meijer,
O. C., Ramirez, M. J., de Kloet,
E. R., and Viveros, M. P. (2011).
Long term sex-dependent psy-
choneuroendocrine effects of mater-
nal deprivation and juvenile unpre-
dictable stress in rats. J. Neuroen-
docrinol. 23, 329–344.
Llorente-Berzal, A., Fuentes, S.,
Gagliano, H., Lopez-Gallardo, M.,
Armario, A., Viveros, M. P., and
Nadal, R. (2011). Sex-dependent
effects of maternal deprivation and
adolescent cannabinoid treatment
on adult rat behaviour. Addict. Biol.
16, 624–637.
López-Gallardo, M., Lopez-Rodriguez,
A. B., Llorente-Berzal, A., Rotl-
lant, D., Mackie, K., Armario, A.,
Nadal, R., and Viveros, M. P. (2011).
Maternal deprivation and adolescent
cannabinoid exposure impact hip-
pocampal astrocytes, CB1 receptors
and brain-derived neurotrophic fac-
tor in a sexually dimorphic fashion.
Neuroscience 204, 90–103.
Lynch, W. J., Nicholson, K. L., Dance,
M. E., Morgan, R. W., and Foley, P.
L. (2010). Animal models of sub-
stance abuse and addiction: implica-
tions for science, animal welfare, and
society. Comp. Med. 60, 177–188.
Lynch, W. J., Roth, M. E., and Carroll,
M. E. (2002). Biological basis of sex
differences in drug abuse: preclinical
and clinical studies. Psychopharma-
cology (Berl.) 164, 121–137.
Maatouk, D. M., and Capel, B. (2008).
Sexual development of the soma in
the mouse. Curr. Top. Dev. Biol. 83,
151–183.
Malone, D. T., Hill, M. N., and Rubino,
T. (2010). Adolescent Cannabis use
and psychosis: epidemiology and
neurodevelopmental models. Br. J.
Pharmacol. 160, 511–522.
Mancini-Marïe, A., Corcoran, C.,
Jimenez, J., Fahim, C., Karama,
S., Beauregard, M., Lévesque, J.,
Mensour, B., Stip, E., and Mendrek,
A. (2008a). Differences in grey
matter density in frontal lobe
regions in men and women with
schizophrenia. Schizophr. Res. 98,
39–40.
Mancini-Marïe, A., Jimenez, J., Corco-
ran, C., Stip, E., Melissa, R., and
Mendrek, A. (2008b). Reversed sex-
ual dimorphism: parietal cortex grey
matter density in women and men
with schizophrenia compared to
matched healthy controls using 3
tesla MRI. Schizophr. Res. 102, 71.
Manna, P. R., Pakarinen, P., El-
Hefnawy, T., and Huhtaniemi, I.
T. (1999). Functional assessment
of the calcium messenger system
in cultured mouse Leydig tumor
cells: regulation of human chori-
onic gonadotropin-induced expres-
sion of the steroidogenic acute reg-
ulatory protein. Endocrinology 140,
1739–1751.
Marco, E. M., Adriani, W., Canese, R.,
Podo, F., Viveros, M. P., and Laviola,
G. (2007). Enhancement of endo-
cannabinoid signalling during ado-
lescence: modulation of impulsiv-
ity and long-term consequences on
metabolic brain parameters in early
maternally deprived rats.Pharmacol.
Biochem. Behav. 86, 334–345.
Mateos, B., Borcel, E., Loriga, R.,
Luesu, W., Bini, V., Llorente, R.,
Castelli, M., and Viveros, M. P.
(2010).Adolescent exposure to nico-
tine and/or the cannabinoid ago-
nist CP 55,940 induces gender-
dependent long-lasting memory
impairments and changes in brain
nicotinic and CB1 cannabinoid
receptors. J. Psychopharmacol. 12,
1676–1690.
Mayer, A., Mosler, G., Just, W., Pilgrim,
C., and Reisert, I. (2000). Develop-
mental proﬁle of Sry transcripts in
mousebrain.Neurogenetics 3,25–30.
Maynard, T. M., Sikich, L., Lieberman,
J. A., and LaMantia, A. S. (2001).
Neural development, cell-cell signal-
ing, and the “two-hit” hypothesis of
schizophrenia. Schizophr. Bull. 27,
457–476.
Mazor, A., Matar, M. A., Kaplan, Z.,
Kozlovsky, N., Zohar, J., and Cohen,
H. (2009). Gender related quali-
tative differences in baseline and
post stress anxiety responses are not
reﬂected in the incidence of criterion
Frontiers in Neuroscience | Neurogenomics June 2012 | Volume 6 | Article 84 | 18
Viveros et al. Neurobehavioral sexual dimorphisms
based PTSD like behaviour patterns.
World J. Biol. Psychiatry 10, 856–869.
McCarthy, M. M., and Arnold, A. P.
(2011). Reframing sexual differenti-
ation of the brain. Nat. Neurosci. 14,
677–683.
McFarlane, A. C., Barton, C. A., Yehuda,
R., and Wittert, G. (2011). Cortisol
response to acute trauma and risk
of posttraumatic stress disorder.Psy-
choneuroendocrinology 36, 720–727.
McGrath, J. J. (2007). The surprisingly
rich contours of schizophrenia epi-
demiology. Arch. Gen. Psychiatry 64,
14–16.
McGrath, J. J., and Susser, E. S. (2009).
New directions in the epidemiol-
ogy of schizophrenia. Med. J. Aust.
190(Suppl. 4), S7–S9.
McGufﬁn, P., Owen, M. J., and Farmer,
A. E. (1995). Genetic basis of schiz-
ophrenia. Lancet 346, 678–682.
Mendelson, J. H., Weiss, R., Grifﬁn, M.,
Mirin,S.M.,Teoh,S. K.,Mello,N.K.,
and Lex, B. W. (1991). Some special
considerations for treatment of drug
abuse and dependence in women.
NIDA Res. Monogr. 106, 313–327.
Mendrek, A. (2007). Reversal of normal
cerebral sexual dimorphism in schiz-
ophrenia: evidence and specula-
tions. Med. Hypotheses 69, 896–902.
Mendrek, A., Lakis, N., and Jimenez, J.
(2011). Associations of sex steroid
hormones with cerebral activa-
tions during mental rotation in
men and women with schizophre-
nia. Psychoneuroendocrinology 36,
1422–1426.
Middaugh, L. D., Kelley, B. M., Bandy,
A. L., and McGroarty, K. K. (1999).
Ethanol consumption by C57BL/6
mice: inﬂuence of gender and proce-
dural variables. Alcohol 17, 175–183.
Miyagawa, S., Satoh, Y., Haraguchi, R.,
Suzuki, K., Iguchi, T., Taketo, M.
M., Nakagata, N., Matsumoto, T.,
Takeyama, K., Kato, S., and Yamada,
G. (2009). Genetic interactions of
the androgen and Wnt/beta-catenin
pathways for the masculinization of
external genitalia. Mol. Endocrinol.
23, 871–880.
Moffat, S. D. (2005). Effects of testos-
terone on cognitive and brain aging
in elderly men. Ann. N. Y. Acad. Sci.
1055, 80–92.
Morgan, C. P., and Bale, T. L.
(2011). Early prenatal stress epige-
netically programs dysmasculiniza-
tion in second-generation offspring
via the paternal lineage. J. Neurosci.
31, 11748–11755.
Mortensen, P. B., Pedersen, C. B., West-
ergaard, T., Wohlfahrt, J., Ewald, H.,
Mors, O., Andersen, P. K., and Mel-
bye, M. (1999). Effects of family his-
tory and place and season of birth on
the risk of schizophrenia. N. Engl. J.
Med. 340, 603–608.
Mueller, B. R., and Bale, T. L. (2008).
Sex-speciﬁc programming of off-
spring emotionality after stress
early in pregnancy. J. Neurosci. 28,
9055–9065.
Mura,A.,Gadau, S., Lepore,G.,Balzano,
F., Zedda, M., Mura, E., and Farina,
V. (2010). Expression and distri-
bution of P450-aromatase in the
ovine hypothalamus at different
stages of fetal development. Neuro
Endocrinol. Lett. 31, 690–699.
Naftolin, F., Leranth, C., Horvath, T.
L., and Garcia-Segura, L. M. (1996).
Potential neuronal mechanisms of
estrogen actions in synaptogenesis
and synaptic plasticity. Cell. Mol.
Neurobiol. 16, 213–223.
Najavits, L. M., and Lester, K. M.
(2008). Gender differences in
cocaine dependence. Drug Alcohol
Depend. 97, 190–194.
National Comorbidity Survey. (2005).
NCS-R appendix tables: Table 1. Life-
time Prevalence of DSM-IV/WMH-
CIDI Disorders by Sex and Cohort.
Table 2. Twelve-Month Preva-
lence of DSM-IV/WMH-CIDI
Disorders by Sex and Cohort.
Available at: http://www.hcp.med.
harvard.edu/ncs/publications.php
Nestler, E. J., and Hyman, S. E. (2010).
Animal models of neuropsychi-
atric disorders. Nat. Neurosci. 13,
1161–1169.
Neylan, T. C., Sun, B., Rempel, H.,
Ross, J., Lenoci, M., O’Donovan,
A., and Pulliam, L. (2011). Sup-
pressed monocyte gene expression
proﬁle in men versus women with
PTSD. Brain Behav. Immun. 25,
524–531.
O’Donovan, A., Sun, B., Cole, S., Rem-
pel, H., Lenoci, M., Pulliam, L., and
Neylan, T. (2011). Transcriptional
control of monocyte gene expres-
sion in post-traumatic stress disor-
der. Dis. Markers 30, 123–132.
O’Hara,M.W., and Swain,A.M. (1996).
Rates and risk of postpartumdepres-
sion – a meta-analysis. Int. Rev.
Psychiatry 8, 37–54.
Pardo,C. A., and Eberhart, C. G. (2007).
The neurobiology of autism. Brain
Pathol. 17, 434–447.
Pask, A. J., Harry, J. L., Graves, J. A.,
O’Neill, R. J., Layﬁeld, S. L., Shaw,
G., and Renfree, M. B. (2002). SOX9
has both conserved and novel roles
in marsupial sexual differentiation.
Genesis 33, 131–139.
Paus, T. (2010a). “Sex differences in
the human brain: a developmen-
tal perspective,” in Progress in Brain
Research,Vol. 186, ed. I. Savic (Stock-
holm: Academic Press), 13–28.
Paus, T. (2010b). Growth of white mat-
ter in the adolescent brain: myelin or
axon. Brain Cogn. 72, 26–35.
Paus, T. (2010c). Population neuro-
science: why and how. Hum. Brain
Mapp. 31, 891–903.
Paus, T., Bernard, M., Chakravarty, M.
M., Davey Smith, G., Gillis, J., Lour-
dusamy, A., Leonard, G., Melka, M.
G., Pavlidis, P., Perron, M., Pike, G.
B., Richer, L., Schumann, G., Timp-
son, N., Toro, R., Veillette, S., and
Pausova,Z. (2011). KCTD8 gene and
brain growth in adverse intrauterine
environment: a genome-wide asso-
ciation study. Cereb. Cortex. doi:
10.1093/cercor/bhr350
Paus, T., Keshavan, M., and Giedd,
J. N. (2008a). Why do many psy-
chiatric disorders emerge during
adolescence? Nat. Rev. Neurosci. 9,
947–957.
Paus, T., Nawazkhan, I., Leonard, G.,
Perron, M., Pike, G. B., Pitiot, A.,
Richer, L., Veillette, S., and Pausova,
Z. (2008b). Corpus callosum in ado-
lescent offspring exposed prenatally
to maternal cigarette smoking. Neu-
roimage 40, 435–441.
Paus, T., Nawaz-Khan, I., Leonard, G.,
Perron, M., Pike, G. B., Pitiot, A.,
Richer, L., Susman, E., Veillette,
S., and Pausova, Z. (2010). Sexual
dimorphism in the adolescent brain:
role of testosterone and androgen
receptor in global and local volumes
of grey and white matter. Horm.
Behav. 57, 63–75.
Paus,T.,Otaky,N.,Caramanos,Z.,Mac-
Donald, D., Zijdenbos, A., D’Avirro,
D., Gutmans, D., Holmes, C.,
Tomaiuolo, F., and Evans, A. C.
(1996). In vivo morphometry of
the intrasulcal gray matter in the
human cingulate, paracingulate, and
superior-rostral sulci: hemispheric
asymmetries, gender differences and
probability maps. J. Comp. Neurol.
376, 664–673.
Paus, T., and Toro, R. (2009).
Could sex differences in white
matter be explained by g
ratio? Front. Neuroanat. 3:14.
doi:10.3389/neuro.05.014.2009
Pausova, Z., Paus, T., Abrahamowicz,
M.,Almerigi, J.,Arbour,N., Bernard,
M., Gaudet, D., Hanzalek, P., Hamet,
P., Evans,A. C., Kramer,M., Laberge,
L., Leal, S., Leonard, G., Lerner, J.,
Lerner, R. M., Mathieu, J., Perron,
M., Pike, B., Pitiot, A., Richer, L.,
Séguin, J. R., Syme, C., Toro, R.,
Tremblay, R. E., Veillette, S., and
Watkins, K. (2007). Genes, mater-
nal smoking and the offspring brain
and body during adolescence: design
of the saguenay youth study. Hum.
Brain Mapp. 28, 502–518.
Peper, J. S., Brouwer, R. M., Van Baal,
G. C., Schnack, H. G., van, L. M.,
Boomsma, D. I., Kahn, R. S., and
Hulshoff Pol,H. E. (2009).Does hav-
ing a twin brother make for a big-
ger brain? Eur. J. Endocrinol. 160,
739–746.
Perrin, J. S., Herve, P. Y., Leonard,
G., Perron, M., Pike, G. B., Pitiot,
A., Richer, L., Veillette, S., Pausova,
Z., and Paus, T. (2008). Growth
of white matter in the adoles-
cent brain: role of testosterone and
androgen receptor. J. Neurosci. 28,
9519–9524.
Peruffo, A., Giacomello, M., Mon-
telli, S., Corain, L., and Cozzi, B.
(2011). Expression and localization
of aromatase P450arom, estrogen
receptor-α, and estrogen receptor-
β in the developing bovine frontal
cortex. Gen. Comp. Endocrinol. 172,
211–217.
Pickens, R., Meisch, R. A., and
Thompson, T. (1978). “Drug self-
administration: an analysis of the
reinforcing effects of drugs,” in
Handbook of Psychopharmacology,
Vol. 12, eds L. L. Iversen, S. P. Iversen,
and S. H. Snyder (NewYork: Plenum
Press), 1–37.
Pignatelli, D., Xiao, F., Gouveia, A. M.,
Ferreira, J. G., and Vinson, G. P.
(2006). Adrenarche in the rat. J.
Endocrinol. 191, 301–308.
Pompolo, S., and Harley, V. R. (2001).
Localisation of the SRY-related
HMG box protein, SOX9, in rodent
brain. Brain Res. 906, 143–148.
Powell, S. B. (2010).Models of neurode-
velopmental abnormalities in schiz-
ophrenia. Curr. Top. Behav. Neurosci.
4, 435–481.
Pratchett, L. C., Pelcovitz, M. R., and
Yehuda, R. (2010). Trauma and
violence: are women the weaker
sex? Psychiatr. Clin. North Am. 33,
465–474.
Randall, C. L., Roberts, J. S., Del Boca,
F. K., Carroll, K. M., Connors, G. J.,
andMattson,M. E. (1999). Telescop-
ing of landmark events associated
with drinking: a gender comparison.
J. Stud. Alcohol 60, 252–260.
Rehn, A. E., and Rees, S. M. (2005).
Investigating the neurodevelopmen-
tal hypothesis of schizophrenia.
Clin. Exp. Pharmacol. Physiol. 32,
687–696.
Reite, M., Sheeder, J., Teale, P., Adams,
M., Richardson, D., Simon, J., Jones,
R. H., and Rojas, D. C. (1997). Mag-
netic source imaging evidence of
sex differences in cerebral lateral-
ization in schizophrenia. Arch. Gen.
Psychiatry 54, 433–440.
Resko, J. A., and Roselli, C. E. (1997).
Prenatal hormones organize sex
www.frontiersin.org June 2012 | Volume 6 | Article 84 | 19
Viveros et al. Neurobehavioral sexual dimorphisms
differences of the neuroendocrine
reproductive system: observations
on guinea pigs and nonhuman pri-
mates. Cell. Mol. Neurobiol. 17,
627–648.
Ressler, K. J., Mercer, K. B., Bradley, B.,
Jovanovic, T., Mahan, A., Kerley, K.,
Norrholm, S. D., Kilaru, V., Smith,
A. K., Myers, A. J., Ramirez, M.,
Engel, A., Hammack, S. E., Toufexis,
D., Braas, K. M., Binder, E. B., and
May,V. (2011). Post-traumatic stress
disorder is associated with PACAP
and the PAC1 receptor. Nature 470,
492–497.
Ring, N., Tantam, D., Montague, L.,
Newby, D., Black, D., and Mor-
ris, J. (1991). Gender differences in
the incidence of deﬁnite schizophre-
nia and atypical psychosis – focus
on negative symptoms of schizo-
phrenia. Acta Psychiatr. Scand. 84,
489–496.
Roberts, D. C., Morgan, D., and Liu,
Y. (2007). How to make a rat
addicted to cocaine. Prog. Neuropsy-
chopharmacol. Biol. Psychiatry 31,
1614–1624.
Roselli, C. E., Estill, C. T., Stadelman,
H. L., Meaker, M., and Stormshak,
F. (2011). Separate critical periods
exist for testosterone-induced dif-
ferentiation of the brain and gen-
itals in sheep. Endocrinology 152,
2409–2415.
Rubino,T., and Parolaro,D. (2011). Sex-
ually dimorphic effects of cannabi-
noid compounds on emotion and
cognition. Front Behav. Neurosci.
5:64. doi:10.3389/fnbeh.2011.00064
Rubino, T., Vigano, D., Realini, N.,
Guidali, C., Braida, D., Capurro,
V., Castiglioni, C., Cherubino, F.,
Romualdi, P., Candeletti, S., Sala,M.,
and Parolaro, D. (2008). Chronic
delta 9-tetrahydrocannabinol
during adolescence provokes
sex-dependent changes in the
emotional proﬁle in adult rats:
behavioral and biochemical corre-
lates. Neuropsychopharmacology 33,
2760–2771.
Rund, B. R., and Borg, N. E. (1999).
Cognitive deﬁcits and cognitive
training in schizophrenic patients:
a review. Acta Psychiatr. Scand. 100,
85–95.
Saha, S., Chant, D., and McGrath, J.
(2007). A systematic review of mor-
tality in schizophrenia: is the dif-
ferential mortality gap worsening
over time? Arch. Gen. Psychiatry 64,
1123–1131.
Saha, S., Chant, D., Welham, J., and
McGrath, J. (2005). A system-
atic review of the prevalence of
schizophrenia. PLoS Med. 2, e141.
doi:10.1371/journal.pmed.0020141
Sanches,M.,Keshavan,M. S.,Brambilla,
P., and Soares, J. C. (2008). Neurode-
velopmental basis of bipolar disor-
der: a critical appraisal. Prog. Neu-
ropsychopharmacol. Biol. Psychiatry
32, 1617–1627.
Schmidt, M. V. (2011). Animal mod-
els for depression and the mismatch
hypothesis of disease. Psychoneu-
roendocrinology 36, 330–338.
Schultz, S. K., Miller, D. D., Oliver, S. E.,
Arndt, S., Flaum,M., andAndreasen,
N. C. (1997). The life course
of schizophrenia: age and symp-
tom dimensions. Schizophr. Res. 23,
15–23.
Schulz, K. M., Molenda-Figueira, H.
A., and Sisk, C. L. (2009). Back
to the future: the organizational-
activational hypothesis adapted to
puberty and adolescence. Horm.
Behav. 55, 597–604.
Schumann, G., Loth, E., Banaschewski,
T., Barbot, A., Barker, G., Büchel,
C., Conrod, P. J., Dalley, J. W., Flor,
H., Gallinat, J., Garavan, H., Heinz,
A., Itterman, B., Lathrop, M., Mallik,
C., Mann, K., Martinot, J.-L., Paus,
T., Poline, J.-B., Robbins, T. W.,
Rietschel, M., Reed, L., Smolka, M.,
Spanagel,R., Speiser,C., Stephens,D.
N., Ströhle, A., Struve, M., and IMA-
GENConsortium. (2010). The IMA-
GEN study: reinforcement-related
behaviour in normal brain function
and psychopathology. Mol. Psychia-
try 15, 1128–1139.
Scott, J. (2006). Depression should be
managed like a chronic disease. BMJ
332, 985–986.
Scotting, P. J., Kordes,U., and Cheng,Y.-
C. (2005). Sox group E gene expres-
sion distinguishes different types
and maturation stages of glial cells
in developing chick and mouse.
Brain Res. Dev. Brain Res. 157,
209–213.
Seeman,M.V. (1996). The role of estro-
gen in schizophrenia. J. Psychiatry
Neurosci. 21, 123–127.
Seeman, M. V. (1997). Psychopathol-
ogy in women and men: focus on
female hormones. Am. J. Psychiatry
154, 1641–1647.
Shen, J. H., and Ingraham,H. A. (2002).
Regulation of the orphan nuclear
receptor steroidogenic factor 1 by
Sox proteins. Mol. Endocrinol. 16,
529–540.
Shirayama, Y., Hashimoto, K., Suzuki,
Y., and Higuchi, T. (2002). Corre-
lation of plasma neurosteroid levels
to the severity of negative symptoms
in male patients with schizophrenia.
Schizophr. Res. 58, 69–74.
Shtasel, D. L., Gur, R. E., Gallacher,
F., Heimberg, C., and Gur, R. C.
(1992). Gender differences in the
clinical expression of schizophrenia.
Schizophr. Res. 7, 225–231.
Sinha, R. (2001). How does stress
increase risk of drug abuse and
relapse? Psychopharmacology (Berl.)
158, 343–359.
Sisk, C. L., and Foster, D. L. (2004). The
neural basis of puberty and adoles-
cence. Nat. Neurosci. 7, 1040–1047.
Smith, D. J., Kyle, S., Forty, L., Cooper,
C., Walters, J., Russell, E., Caesar, S.,
Farmer, A., McGufﬁn, P., Jones, I.,
Jones, L., and Craddock, N. (2008).
Differences in depressive symptom
proﬁle between males and females.
J. Affect. Disord. 108, 279–284.
Sprock, J., and Yoder, C. Y. (1997).
Women and depression: an update
on the report of the APA task force.
Sex Roles 36, 269–303.
Suarez, J., Llorente, R., Romero-Zerbo,
S. Y., Mateos, B., Bermudez-Silva,
F. J., de Fonseca, F. R., and
Viveros, M. P. (2009). Early mater-
nal deprivation induces gender-
dependent changes on the expres-
sion of hippocampal CB(1) and
CB(2) cannabinoid receptors of
neonatal rats. Hippocampus 19,
623–632.
Suarez, J., Rivera, P., Llorente, R.,
Romero-Zerbo, S. Y., Bermudez-
Silva, F. J., de Fonseca, F. R., and
Viveros, M. P. (2010). Early mater-
nal deprivation induces changes on
the expression of 2-AG biosynthesis
and degradation enzymes in neona-
tal rat hippocampus.BrainRes.1349,
162–173.
Sullivan, P. F.,Neale,M. C., and Kendler,
K. S. (2000). Genetic Epidemiol-
ogy of major depression: review and
meta-analysis. Am. J. Psychiatry 157,
1552–1562.
Szulc, A., Galinska, B., and
Czernikiewicz, A. (2005). Schizo-
phrenia – neurodevelopmental and
neurodegenerative theory revisited.
Psychiatr. Pol. 39, 249–258.
Szymanski, S., Lieberman, J. A., Alvir,
J. M., Mayerhoff, D., Loebel, A.,
Geisler, S., Chakos, M., Koreen, A.,
Jody, D., Kane, J., et al. (1995). Gen-
der differences in onset of illness,
treatment response, course, and bio-
logic indexes in ﬁrst-episode schiz-
ophrenic patients. Am. J. Psychiatry
152, 698–703.
Takahashi, T., Suzuki, M., Kawasaki, Y.,
Hagino, H., Yamashita, I., Nohara,
S., Nakamura, K., Seto, H., and
Kurachi, M. (2003). Perigenual cin-
gulate gyrus volume in patients with
schizophrenia: amagnetic resonance
imaging study. Biol. Psychiatry 53,
593–600.
Takahashi, T., Suzuki, M., Zhou, S. Y.,
Hagino, H., Kawasaki, Y., Yamashita,
I., Nohara, S., Nakamura, K., Seto,
H., and Kurachi, M. (2004). Lack
of normal gender differences of the
perigenual cingulate gyrus in schizo-
phrenia spectrum disorders. A mag-
netic resonance imaging study. Eur.
Arch. Psychiatry Clin. Neurosci. 254,
273–280.
Takai, N., Yamaguchi, M., Aragaki,
T., Eto, K., Uchihashi, K., and
Nishikawa, K. (2007). Gender-
speciﬁc differences in salivary
biomarker responses to acute
psychological stress. Ann. N. Y.
Acad. Sci. 1098, 510–515.
Takei, N., Van Os, J., and Murray, R.
M. (1995). Maternal exposure to
inﬂuenza and risk of schizophre-
nia: a 22 year study from The
Netherlands. J. Psychiatr. Res. 29,
435–445.
Thornton, J., Zehr, J. L., and Loose,
M. D. (2009). Effects of prenatal
androgens on rhesus monkeys:
a model system to explore
the organizational hypothesis
in primates. Horm. Behav. 55,
633–645.
Tolin, D. F., and Foa, E. B. (2006).
Sex differences in trauma and
posttraumatic stress disorder: a
quantitative review of 25 years
of research. Psychol. Bull. 132,
959–992.
Toro, R., Leonard, G., Lerner, J. V.,
Lerner, R. M., Perron,M., Pike,G. B.,
Richer, L., Veillette, S., Pausova, Z.,
and Paus, T. (2008). Prenatal expo-
sure to maternal cigarette smok-
ing and the adolescent cerebral cor-
tex. Neuropsychopharmacology 33,
1019–1027.
Trivedi, M. H., Rush, A. J., Wisniewski,
S. R., Nierenberg, A. A., Warden,
D., Ritz, L., Norquist, G., How-
land, R. H., Lebowitz, B., McGrath,
P. J., Shores-Wilson, K., Biggs, M.
M., Balasubramani, G. K., and
Fava, M. (2006). Evaluation of out-
comes with citalopram for depres-
sion using measurement-based care
in STAR D: implications for clini-
cal practice. Am. J. Psychiatry 163,
28–40.
Troutman, B. R., and Cutrona, C.
E. (1990). Nonpsychotic postpar-
tum depression among adolescent
mothers. J. Abnorm. Psychol. 99,
69–78.
Vierhapper, H., Nowotny, P., and Wald-
hausl, W. (1998). Sex-speciﬁc dif-
ferences in cortisol production rates
in humans. Metab. Clin. Exp. 47,
974–976.
Vilain, E., and McCabe, E. R. (1998).
Mammalian sex determination:
from gonads to brain. Mol. Genet.
Metab. 65, 74–84.
Frontiers in Neuroscience | Neurogenomics June 2012 | Volume 6 | Article 84 | 20
Viveros et al. Neurobehavioral sexual dimorphisms
Viveros, M. P., Bermúdez-Silva, F. J.,
López-Rodríguez, A. B., and Wag-
ner, E. J. (2011a). The endocannabi-
noid system as pharmacological tar-
get derived from its CNS role in
energy homeostasis and reward.
Applications in eating disorders
and addiction. Pharmaceuticals 8,
1101–1136.
Viveros, M. P., Llorente, R., Suarez, J.,
Llorente-Berzal, A., Lopez-Gallardo,
M., and Rodriguez de, F. F. (2011b).
The endocannabinoid system in crit-
ical neurodevelopmental periods:
sex differences and neuropsychi-
atric implications. J. Psychopharma-
col. (Oxford) 26, 164–176.
Viveros, M. P., Llorente, R., Lopez-
Gallardo, M., Suarez, J., Bermudez-
Silva, F., De la Fuente, M., Rodriguez
de Fonseca, F., and Garcia-Segura,
L. M. (2009). Sex-dependent alter-
ations in response to maternal
deprivation in rats. Psychoneu-
roendocrinology 34(Suppl. 1),
S217–S226.
Wagner, C. K., Xu, J., Pfau, J. L.,
Quadros, P. S., de Vries, G. J., and
Arnold, A. P. (2004). Neonatal mice
possessing an Sry transgene show
a masculinized pattern of proges-
terone receptor expression in the
brain independent of sex chro-
mosome status. Endocrinology 145,
1046–1049.
Weinberg, J., Sliwowska, J. H., Lan, N.,
and Hellemans, K. G. (2008). Prena-
tal alcohol exposure: foetal program-
ming, the hypothalamic-pituitary-
adrenal axis and sex differences
in outcome. J. Neuroendocrinol. 20,
470–488.
Weissman, M. M., and Olfson, M.
(1995). Depression in women:
implications for health care research.
Science 269, 799–801.
Wittmann, W., and McLennan, I. S.
(2011). The male bias in the num-
ber of Purkinje cells and the size of
the murine cerebellum may require
Müllerian inhibiting substance/anti-
Müllerian hormone. J. Neuroen-
docrinol. 23, 831–838.
Wu, J. B., Chen, K., Li, Y., Lau, Y.-F. C.,
and Shih, J. C. (2009). Regulation of
monoamine oxidase A by the SRY
gene on the Y chromosome. FASEB
J. 23, 4029–4038.
Xu, J., Burgoyne, P. S., and Arnold,
A. P. (2002). Sex differences in
sex chromosome gene expression in
mouse brain. Hum. Mol. Genet. 11,
1409–1419.
Yehuda, R. (2002). Current status of
cortisol ﬁndings in post-traumatic
stress disorder. Psychiatr. Clin. North
Am. 25, 341–368.
Yehuda, R. (2006). Advances in under-
standing neuroendocrine alterations
in PTSDand their therapeutic impli-
cations. Ann. N. Y. Acad. Sci. 1071,
137–166.
Yehuda, R., Flory, J., Pratchett, L.,
Buxbaum, J., Ising, M., and Hols-
boer, F. (2010). Putative biologi-
cal mechanisms for the associa-
tion between early life adversity
and the subsequent development of
PTSD. Psychopharmacology (Berl.)
212, 405–417.
Zlotnick, C., Zimmerman, M., Wolfs-
dorf, B. A., and Mattia, J. I. (2001).
Gender differences in patients
with posttraumatic stress dis-
order in a general psychiatric
practice. Am. J. Psychiatry 158,
1923–1925.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential
conﬂict of interest.
Received: 06 December 2011; accepted:
18 May 2012; published online: June
2012.
Citation: Viveros M-P, Mendrek A,
Paus T, López-Rodríguez AB, Marco
EM, Yehuda R, Cohen H, Lehrner
A and Wagner EJ (2012) A com-
parative, developmental, and clinical
perspective of neurobehavioral sexual
dimorphisms. Front. Neurosci. 6:84. doi:
10.3389/fnins.2012.00084
This article was submitted to Frontiers in
Neurogenomics, a specialty of Frontiers in
Neuroscience.
Copyright © 2012 Viveros, Mendrek,
Paus, López-Rodríguez, Marco, Yehuda,
Cohen, Lehrner and Wagner. This is an
open-access article distributed under the
terms of the Creative Commons Attribu-
tion Non Commercial License, which per-
mits non-commercial use, distribution,
and reproduction in other forums, pro-
vided the original authors and source are
credited.
www.frontiersin.org June 2012 | Volume 6 | Article 84 | 21
12
